"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B2,US 7128940 B2,035-277-570-945-949,2006-10-31,2006,US 62357303 A,2003-07-22,US 62357303 A;;US 40201902 P,2002-08-08,Use of carbohydrate-based metal complexes in non-caking salt compositions,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,AKZO NOBEL N.V (2003-09-19);;AKZO NOBEL CHEMICALS INTERNATIONAL B.V (2017-08-31),https://lens.org/035-277-570-945-949,Granted Patent,yes,15,2,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,426/649;;426/74;;426/506;;426/519;;426/656;;426/658,0,0,,,,ACTIVE
2,DK,T3,DK 1546038 T3,083-692-255-632-327,2006-08-14,2006,DK 03792204 T,2003-07-16,US 40201902 P,2002-08-08,Anvendelse af carbohydratbaserede metalkomplekser i ikke kagedannende saltsammensætninger,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/083-692-255-632-327,Granted Patent,no,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
3,PL,A1,PL 373865 A1,010-856-359-305-005,2005-09-19,2005,PL 37386503 A,2003-07-16,US 40201902 P,2002-08-08,USE OF CARBOHYDRATE-BASED METAL COMPLEXES IN NON-CAKING SALT COMPOSITIONS,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/010-856-359-305-005,Patent Application,no,0,0,20,20,0,C01D3/26;;C01D3/26,C01D3/26;;A23L27/40;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
4,CN,C,CN 100348488 C,061-543-282-937-014,2007-11-14,2007,CN 03818828 A,2003-07-16,US 40201902 P,2002-08-08,Use of carbohydrate-based metal complexes in non-caking salt compositions,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,MICHAEL GEERTMAN ROBERT,,https://lens.org/061-543-282-937-014,Granted Patent,no,3,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
5,AU,A1,AU 2003/250965 A1,132-541-228-471-705,2004-03-11,2004,AU 2003/250965 A,2003-07-16,EP 0307695 W;;US 40201902 P,2002-08-08,USE OF CARBOHYDRATE-BASED METAL COMPLEXES IN NON-CAKING SALT COMPOSITIONS,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/132-541-228-471-705,Patent Application,no,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,DISCONTINUED
6,ES,T3,ES 2262005 T3,089-985-042-860-278,2006-11-16,2006,ES 03792204 T,2003-07-16,US 40201902 P,2002-08-08,USO DE COMPLEJOS METALICOS A BASE DE CARBOHIDRATOS EN COMPOSICIONES DE SAL QUE NO SE AGLOMEREAN.,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/089-985-042-860-278,Granted Patent,no,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
7,US,A1,US 2005/0079273 A1,137-737-501-353-459,2005-04-14,2005,US 62357303 A,2003-07-22,US 62357303 A;;US 40201902 P,2002-08-08,Use of carbohydrate-based metal complexes in non-caking salt compositions,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,AKZO NOBEL N.V (2003-09-19);;AKZO NOBEL CHEMICALS INTERNATIONAL B.V (2017-08-31),https://lens.org/137-737-501-353-459,Patent Application,yes,6,2,20,20,0,C01D3/26;;C01D3/26,C01D3/26;;A23L27/40;;C09K3/18;;C25B1/26,426/658,0,0,,,,EXPIRED
8,PL,B1,PL 213118 B1,055-528-357-919-45X,2013-01-31,2013,PL 37386503 A,2003-07-16,US 40201902 P,2002-08-08,USE OF CARBOHYDRATE-BASED METAL COMPLEXES IN NON-CAKING SALT COMPOSITIONS,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/055-528-357-919-45X,Granted Patent,no,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C09K3/18;;C01D3/26;;C25B1/26,,0,0,,,,EXPIRED
9,EP,B1,EP 1546038 B1,136-229-520-372-412,2006-05-10,2006,EP 03792204 A,2003-07-16,EP 0307695 W;;US 40201902 P,2002-08-08,USE OF CARBOHYDRATE-BASED METAL COMPLEXES IN NON-CAKING SALT COMPOSITIONS,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,"AKZO NOBEL CHEMICALS INTERNATIONAL B.V.; NL (2017-11-07);;AKZO NOBEL N.V., NL (2013-12-13);;AKZO NOBEL CHEMICALS INTERNATIONAL B.V., NL (2018-05-15);;AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (2018-01-22)",https://lens.org/136-229-520-372-412,Granted Patent,yes,2,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
10,TW,A,TW 200413253 A,098-973-059-279-55X,2004-08-01,2004,TW 92121648 A,2003-08-07,US 40201902 P,2002-08-08,The use of carbohydrate-based metal complexes in non-caking salt compositions,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/098-973-059-279-55X,Patent of Addition,no,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C09K3/18;;C01D3/26;;C25B1/26,,0,0,,,,EXPIRED
11,AT,T1,AT E325777 T1,183-655-857-422-258,2006-06-15,2006,AT 03792204 T,2003-07-16,US 40201902 P,2002-08-08,VERWENDUNG VON AUF KOHLENHYDRAT BASIERENDEN METALLKOMPLEXEN IN NICHTVERKLEBENDEN SALZZUSAMMENSETZUNGEN,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/183-655-857-422-258,Granted Patent,no,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
12,TW,B,TW I265150 B,131-538-025-486-41X,2006-11-01,2006,TW 92121648 A,2003-08-07,US 40201902 P,2002-08-08,The use of carbohydrate-based metal complexes in non-caking salt compositions,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/131-538-025-486-41X,Granted Patent,no,0,0,20,20,0,C01D3/26;;C01D3/26,C09K3/18;;A23L27/40;;C25B1/26;;C01D3/26,,0,0,,,,EXPIRED
13,WO,A1,WO 2004/018362 A1,011-654-327-126-222,2004-03-04,2004,EP 0307695 W,2003-07-16,US 40201902 P,2002-08-08,USE OF CARBOHYDRATE-BASED METAL COMPLEXES IN NON-CAKING SALT COMPOSITIONS,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,,https://lens.org/011-654-327-126-222,Patent Application,yes,2,0,20,20,0,C01D3/26;;C01D3/26,C01D3/26;;C09K3/18;;C25B1/26;;A23L27/40,,0,0,,,,PATENTED
14,CN,A,CN 1675130 A,095-978-334-742-929,2005-09-28,2005,CN 03818828 A,2003-07-16,US 40201902 P,2002-08-08,Use of carbohydrate-based metal complexes in non-caking salt compositions,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,MICHAEL GEERTMAN ROBERT,,https://lens.org/095-978-334-742-929,Patent Application,no,0,4,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
15,EP,A1,EP 1546038 A1,131-092-244-864-261,2005-06-29,2005,EP 03792204 A,2003-07-16,EP 0307695 W;;US 40201902 P,2002-08-08,USE OF CARBOHYDRATE-BASED METAL COMPLEXES IN NON-CAKING SALT COMPOSITIONS,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL,"AKZO NOBEL CHEMICALS INTERNATIONAL B.V.; NL (2017-11-07);;AKZO NOBEL N.V., NL (2013-12-13);;AKZO NOBEL CHEMICALS INTERNATIONAL B.V., NL (2018-05-15);;AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (2018-01-22)",https://lens.org/131-092-244-864-261,Patent Application,yes,0,0,20,20,0,C01D3/26;;C01D3/26,A23L27/40;;C01D3/26;;C09K3/18;;C25B1/26,,0,0,,,,EXPIRED
16,PT,E,PT 1546038 E,175-249-599-348-580,2006-08-31,2006,PT 03792204 T,2003-07-16,US 40201902 P,2002-08-08,UTILIZACAO DE COMPLEXOS METALICOS BASEADOS EM HIDRATO DE CARBONO EM COMPOSICOES DE SAL ANTI- AGLOMERACAO,"The present invention relates to a non-caking salt composition wherein the salt is an inorganic salt, comprising a transition metal complex or an aluminium complex of a (derivatised) carbohydrate as a non-caking agent. Transition metals which can be used according to the present invention are transition metals capable of forming octahedral mixed chloride-oxide structures. The non-caking salt compositions according to the invention can be used as table salt, road salt, or in electrolysis operations.",AKZO NOBEL NV,MICHAEL GEERTMAN ROBERT,,https://lens.org/175-249-599-348-580,Granted Patent,no,0,0,20,20,0,C01D3/26;;C01D3/26,C01D3/26;;C09K3/18;;A23L27/40;;C25B1/26,,0,0,,,,EXPIRED
17,EP,A1,EP 3320104 A1,116-020-657-705-457,2018-05-16,2018,EP 16738144 A,2016-07-11,US 201562191007 P;;EP 2016066444 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,,DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/116-020-657-705-457,Patent Application,yes,0,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/44;;A23L27/30;;C12N15/82,,0,0,,,,ACTIVE
18,EP,A1,EP 0757663 A1,071-550-690-417-489,1997-02-12,1997,EP 96900400 A,1996-01-25,EP 96900400 A;;EP 95200239 A;;IB 9600060 W,1995-02-01,OPTICAL FIBER HAVING REDUCED POLARISATION MODE DISPERSION,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,"DRAKA COMTEQ B.V. (2012-02-29);;DRAKA COMTEQ B.V., NL (2012-03-08)",https://lens.org/071-550-690-417-489,Patent Application,yes,0,0,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,,1,0,,,See references of WO 9623739A1,EXPIRED
19,BR,B1,BR 112018000550 B1,016-845-286-987-90X,2022-05-10,2022,BR 112018000550 A,2016-07-11,EP 2016066444 W;;US 201562191007 P,2015-07-10,Método para preparar uma composição de glicosídeo de esteviol,"composição de glicosídeo de esteviol, método para preparar uma composição de glicosídeo de esteviol e método para reduzir o teor de nitrogênio de uma composição de glicosídeo de esteviol. a presente invenção se refere a uma composição que compreende um ou mais glicosídeos de esteviol cuja composição compreende nitrogênio em uma quantidade de não mais que cerca de 1000 ppm. a invenção também se refere a um método para preparar uma composição de glicosídeo de esteviol, em que o método compreende: fornecer uma composição de glicosídeo de esteviol; combinar a composição de glicosídeo de esteviol com água para formar uma solução de glicosídeo de esteviol; e cristalizar uma composição de glicosídeo de esteviol a partir da solução. a invenção também se refere a um método para reduzir o teor de nitrogênio de uma composição de glicosídeo de esteviol, em que o método compreede: fornecer uma composição de glicosídeo de esteviol que compreende nitrogênio; combinar a composição de glicosídeo de esteviol com água para formar uma solução de glicosídeo de esteviol; e cristalizar uma composição de glicosídeo de esteviol a partir da solução, para reduzir, através disso, a quantidade de nitrogênio na composição de glicosídeo de esteviol.",DSM IP ASSETS BV,GALAEV IGOR;;GEERTMAN ROBERT,,https://lens.org/016-845-286-987-90X,Granted Patent,no,0,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12N15/82;;A23L27/30;;C12P19/44,,0,0,,,,ACTIVE
20,BR,A2,BR 112018000298 A2,115-813-034-574-685,2018-09-04,2018,BR 112018000298 A,2016-07-11,EP 2016066443 W;;US 201562191023 P,2015-07-10,composição de glicosídeo de esteviol,,DSM IP ASSETS BV,IGOR GALAEV;;ROBERT GEERTMAN,,https://lens.org/115-813-034-574-685,Patent Application,no,0,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;A23L27/30;;C12N15/82;;C12P19/44,,0,0,,,,ACTIVE
21,US,A1,US 2018/0371516 A1,129-188-288-229-109,2018-12-27,2018,US 201615742561 A,2016-07-11,US 201615742561 A;;US 201562191007 P;;EP 2016066444 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000 ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,DSM IP ASSETS B.V (2017-12-15),https://lens.org/129-188-288-229-109,Patent Application,yes,0,4,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/56;;A23L2/60;;A23L27/30;;A23L33/20,,0,0,,,,ACTIVE
22,WO,A1,WO 1996/023739 A1,044-155-354-710-046,1996-08-08,1996,IB 9600060 W,1996-01-25,EP 95200239 A,1995-02-01,OPTICAL FIBER HAVING REDUCED POLARISATION MODE DISPERSION,"A method of manufacturing an optical fiber comprising a core portion with a dopant and a surrounding optical cladding portion, comprising the steps of drawing a fiber (7) from a molten extremity (3) of a silica preform (1) and moving the fiber (7) along means (9) for coating it with a protective sheath, whereby, prior to the coating step, the moving fiber (7) is irradiated with irregularly modulated actinic radiation (15), thereby causing corresponding irregular variations in the refractive index of its core portion as a function of longitudinal position. The resulting fiber demonstrates a significantly reduced polarisation mode dispersion.",PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,,https://lens.org/044-155-354-710-046,Patent Application,yes,3,10,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,G2J JGBA1         JGBA1,0,0,,,,PATENTED
23,US,A1,US 2021/0310034 A1,001-477-621-992-634,2021-10-07,2021,US 202117351509 A,2021-06-18,US 202117351509 A;;US 201815742561 A;;EP 2016066444 W;;US 201562191007 P,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000 ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,DSM IP ASSETS B.V (2017-12-15),https://lens.org/001-477-621-992-634,Patent Application,yes,1,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/56;;A23L2/60;;A23L27/30;;A23L33/20;;C12P19/44,,0,0,,,,DISCONTINUED
24,EP,A1,EP 3319974 A1,013-984-472-170-443,2018-05-16,2018,EP 16738408 A,2016-07-11,US 201562191023 P;;EP 2016066443 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,,DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/013-984-472-170-443,Patent Application,yes,0,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;A23L27/30;;C12N15/82;;C12P19/44,,0,0,,,,PENDING
25,MY,A,MY 192153 A,108-601-632-551-362,2022-08-02,2022,MY PI2017704778 A,2016-07-11,EP 2016066444 W;;US 201562191007 P,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/108-601-632-551-362,Granted Patent,no,0,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C07H1/08;;C12N15/82;;C12P19/44,,0,0,,,,ACTIVE
26,EP,A1,EP 0785913 A1,150-567-988-954-53X,1997-07-30,1997,EP 96929243 A,1996-08-12,EP 96929243 A;;EP 9603566 W;;EP 95202216 A,1995-08-16,OPTICAL FIBER WITH LOW POLARISATION MODE DISPERSION,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,"DRAKA COMTEQ B.V. (2012-02-29);;DRAKA COMTEQ B.V., NL (2012-03-08)",https://lens.org/150-567-988-954-53X,Patent Application,yes,0,0,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,C03B37/027;;C03B37/03;;G02B6/02;;G02B6/00,,0,0,,,,EXPIRED
27,BR,A2,BR 112018000550 A2,027-744-770-251-415,2018-09-18,2018,BR 112018000550 A,2016-07-11,EP 2016066444 W;;US 201562191007 P,2015-07-10,composição de glicosídeo de esteviol,,DSM IP ASSETS BV,IGOR GALAEV;;ROBERT GEERTMAN,,https://lens.org/027-744-770-251-415,Patent Application,no,0,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12N15/82;;A23L27/30;;C12P19/44,,0,0,,,,ACTIVE
28,US,A,US 5897680 A,063-411-959-670-517,1999-04-27,1999,US 69864196 A,1996-08-16,EP 95202216 A,1995-08-16,Method of making a twisted optical fiber with low polarisation mode dispersion,"A method of manufacturing an optical fiber, whereby a fiber is drawn from a molten extremity of a preform and is subsequently subjected to a torque, thereby causing a portion of the fiber to be twisted about its longitudinal axis and to be endowed with a spin. The torque is applied by running the fiber between a pair of wheels which rotate in mutually opposite senses about two different rotational axes, each wheel having a peripheral curved surface, the wheels being thus arranged that the fiber runs substantially tangential to their curved surfaces and is pressed therebetween, the wheels being moved back and forth relative to one another in a direction substantially perpendicular to the fiber so as to cause the fiber to be rolled back and forth between their curved surfaces.",PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT E M,PLASMA OPTICAL FIBRE B.V (1998-06-30);;DRAKA COMTEQ B.V (2007-08-02);;U.S.PHILIPS CORPORATION (1996-09-11),https://lens.org/063-411-959-670-517,Granted Patent,yes,10,38,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,C03B37/027;;G02B6/02;;C03B37/03;;G02B6/00,65/402;;65/504;;57/293;;57/294,1,1,057-470-096-808-770,10.1109/50.7889,"C.G. Askins et al, Technique for controlling the Internal Rotation of Principal Axes in the Fabrication of Birefringent Fibers , IEEE Journal of Lightwave Technology, vol. 6, No. 9, Sep. 1988, pp. 1402 1405.",EXPIRED
29,CN,A,CN 1147804 A,026-728-366-460-278,1997-04-16,1997,CN 96190143 A,1996-01-25,EP 95200239 A,1995-02-01,Optical fiber having reduced polarisation mode dispersion,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,"DRAKA COMMUNICATIONS TECHNOLOGY CO., LTD. (2008-03-07)",https://lens.org/026-728-366-460-278,Patent Application,no,0,3,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,,0,0,,,,EXPIRED
30,CN,C,CN 1093842 C,143-416-378-958-670,2002-11-06,2002,CN 96190143 A,1996-01-25,EP 95200239 A,1995-02-01,Optical fiber having reduced polarisation mode dispersion,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,"DRAKA COMMUNICATIONS TECHNOLOGY CO., LTD. (2008-03-07)",https://lens.org/143-416-378-958-670,Granted Patent,no,2,0,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,,0,0,,,,EXPIRED
31,EP,B1,EP 3320104 B1,075-406-835-011-818,2021-11-10,2021,EP 16738144 A,2016-07-11,US 201562191007 P;;EP 2016066444 W,2015-07-10,METHOD FOR PREPARING A STEVIOL GLYCOSIDE COMPOSITION,,DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/075-406-835-011-818,Granted Patent,yes,2,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/44;;A23L27/30;;C12N15/82,,0,0,,,,ACTIVE
32,MY,A,MY 192148 A,118-544-135-985-842,2022-08-02,2022,MY PI2017704777 A,2016-07-11,EP 2016066443 W;;US 201562191023 P,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises kaurenoic acid in an amount of no more than 150ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0 or below. The invention also relates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises kaurenoic acid; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0, thereby to reduce the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/118-544-135-985-842,Granted Patent,no,0,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;C12N15/82;;C12P19/44,,0,0,,,,ACTIVE
33,US,A1,US 2018/0371003 A1,003-713-836-308-507,2018-12-27,2018,US 201615742355 A,2016-07-11,US 201615742355 A;;US 201562191023 P;;EP 2016066443 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises kaurenoic acid in an amount of no more than 150 ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0 or below. The invention also relates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises kaurenoic acid; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0, thereby to reduce the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,DSM IP ASSETS B.V (2017-12-15),https://lens.org/003-713-836-308-507,Patent Application,yes,6,3,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H15/256;;A23L27/30;;C07H1/06,,0,0,,,,ACTIVE
34,EP,A1,EP 4043579 A1,116-454-592-632-848,2022-08-17,2022,EP 21206463 A,2016-07-11,US 201562191007 P;;EP 16738144 A;;EP 2016066444 W,2015-07-10,METHOD FOR PREPARING A STEVIOL GLYCOSIDE COMPOSTION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/116-454-592-632-848,Patent Application,yes,18,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/44;;A23L27/30,,8,3,063-770-860-805-05X;;099-845-086-004-957;;038-063-517-554-83X,16786291;;10.1007/s11103-005-5966-9;;10.1016/j.jplph.2011.01.030;;21477883;;10.1021/ac60182a815,"YOHANES MARTONO ET AL.: ""Water-based crystallization and formulation of Stevioside from Stevia rebaudiana (Bert.) as natural sweetener with antidiabetic activity"", December 2012 (2012-12-01), pages 1 - 8, XP002760704, Retrieved from the Internet <URL:http://ris.uksw.edu/download/makalah/kode/M00752> [retrieved on 20160810];;ANONYMOUS: ""Manufacturing of our products"", 19 January 2012 (2012-01-19), pages 1 - 2, XP002760705, Retrieved from the Internet <URL:http://web.archive.org/web/20120119233148/http://en.sucrevia.com/stevia/why-our-stevia-products.html> [retrieved on 20160810];;DATABASE WPI Week 201213, Derwent World Patents Index; AN 2011-Q34574, XP002702395;;HUMPHREY ET AL., PLANT MOLECULAR BIOLOGY, vol. 61, 2006, pages 47 - 62;;MOHAMED ET AL., PLANT PHYSIOLOGY, vol. 168, 2011, pages 1136 - 1141;;ALEXOPOULOS, C. J.: ""Introductory Mycology"", 1962, JOHN WILEY & SONS, INC.;;SAMBROOKRUSSEL: ""Molecular Cloning: A Laboratory Manual"", 2001, COLD SPRING HARBOR LABORATORY;;""Current protocols in molecular biology"", 1987, WILEY INTERSCIENCE",DISCONTINUED
35,CN,A,CN 107820394 A,160-330-415-943-785,2018-03-20,2018,CN 201680040080 A,2016-07-11,US 201562191007 P;;EP 2016066444 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000ppm. The invention also relates toa method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, whichmethod comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/160-330-415-943-785,Patent Application,no,4,3,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,A23L27/30;;C12P19/44,,0,0,,,,PENDING
36,CA,A1,CA 2991651 A1,198-118-187-184-553,2017-01-19,2017,CA 2991651 A,2016-07-11,US 201562191007 P;;EP 2016066444 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/198-118-187-184-553,Patent Application,no,0,0,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/44;;A23L27/30;;C12N15/82,,0,0,,,,PENDING
37,EP,B1,EP 0757663 B1,003-418-622-394-137,1998-05-13,1998,EP 96900400 A,1996-01-25,EP 96900400 A;;EP 95200239 A;;IB 9600060 W,1995-02-01,OPTICAL FIBER HAVING REDUCED POLARISATION MODE DISPERSION,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,"DRAKA COMTEQ B.V. (2012-02-29);;DRAKA COMTEQ B.V., NL (2012-03-08)",https://lens.org/003-418-622-394-137,Granted Patent,yes,3,0,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,,0,0,,,,EXPIRED
38,DE,D1,DE 69600288 D1,017-225-903-978-865,1998-06-18,1998,DE 69600288 T,1996-01-25,EP 95200239 A;;IB 9600060 W,1995-02-01,OPTISCHE FASER MIT VERRINGERTER POLARISATIONSMODENDISPERSION,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,,https://lens.org/017-225-903-978-865,Granted Patent,no,0,0,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,,0,0,,,,EXPIRED
39,CN,C,CN 1210588 C,062-781-601-266-829,2005-07-13,2005,CN 03107636 A,2003-03-20,EP 95202216 A,1995-08-16,Optical fibre with low polarisation mode dispersion,,PLASMA OPTICAL FIBRE BV,MARIE GEERTMAN ROBERT EUGENIO,"DRAKA COMMUNICATIONS TECHNOLOGY CO., LTD. (2008-03-07)",https://lens.org/062-781-601-266-829,Granted Patent,no,0,0,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,G02B6/02;;C03B37/027;;C03B37/03;;G02B6/00,,0,0,,,,EXPIRED
40,US,A,US 5992181 A,170-082-858-771-161,1999-11-30,1999,US 3133098 A,1998-02-26,US 3133098 A;;EP 95200239 A;;US 59399596 A,1995-02-01,Method of randomly irradiating an optical fiber core with a laser,"A method of manufacturing an optical fiber having a core portion doped with a dopant and a surrounding optical cladding portion is disclosed. The method comprises the steps of drawing a fiber from a molten extremity of a silica preform and moving the fiber along towards a device for coating it with a protective sheath. Prior to the coating step, the moving fiber is irradiated with irregularly modulated actinic radiation, thereby causing corresponding irregular variations in the refractive index of its core portion as a function of longitudinal position. The resulting fiber demonstrates a significantly reduced polarisation mode dispersion.",PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,PLASMA OPTICAL FIBRE B.V (1998-06-30);;DRAKA COMTEQ B.V (2012-01-12),https://lens.org/170-082-858-771-161,Granted Patent,yes,6,20,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,65/392;;65/425;;250/492.1;;430/290;;430/321,2,0,,,"Foreign Search Report dated Apr. 2, 1996 (Internation Application No. PCT/IB/96100060.;;Fiber Laser Sources and Amplifiers II , by Russell et al., SPIE Conf. Pro. Vol. 1373 (1990), Fiber Laser Sources and Amplifiers II, pp. 126 139.",EXPIRED
41,US,B2,US 11124535 B2,011-562-184-320-854,2021-09-21,2021,US 201615742355 A,2016-07-11,US 201615742355 A;;US 201562191023 P;;EP 2016066443 W,2015-07-10,Steviol glycoside composition,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises kaurenoic acid in an amount of no more than 150 ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0 or below. The invention also relates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises kaurenoic acid; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0, thereby to reduce the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,DSM IP ASSETS B.V (2017-12-15),https://lens.org/011-562-184-320-854,Granted Patent,yes,19,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H15/256;;A23L27/30;;C07H1/06,,5,2,063-770-860-805-05X;;012-589-427-993-866,16786291;;10.1007/s11103-005-5966-9;;8806729;;10.1006/abbi.1996.0336,"International Search Report from corresponding PCT/EP2016/066443, dated Aug. 30, 2016.;;Yohanes Martono et al . : Water-based crystallization and formulation of Stevioside from Stevia rebaudiana (Bert.) as natural sweetener with antidiabetic activity, Dec. 2012 (Dec. 2012), pp. 1-8.;;Humphrey TV et al: Spatial organization of four enzymes from Stevia rebaudiana that are involved in steviol glycoside synthesis, Plant Molecular Biology, Springer, Dordrecht, NL, vol. 61, No. 1-2, May 1, 2006 (May 1, 2006}, pp. 47-62.;;DATABASE WPI/THOMSON 1 January 1900 (1900-01-01), KITAHARA T, MATSUSHITA K: ""Sepn. of stevioside and rebaudioside A - by crystallising mixt. in aq. (m)ethanol, adding obtd. crystals to water and recovering solid stevioside"", XP002469090, Database accession no. 1981-82358D;;Kim Keun Ki et al: “Hydroxylation of ent-kaurenoic acid to steviol in Stevia rebaudiana Bertoni-purification and partial characterization of the enzyme”, Archives of Biochemistry and Biophysics, Academic Press, US, vol. 332, No. 2, Aug. 15, 1996 (Aug. 15, 1996), pp. 223-230.",ACTIVE
42,US,A,US 6148131 A,174-892-660-927-757,2000-11-14,2000,US 18348398 A,1998-10-30,US 18348398 A;;EP 95202216 A;;US 69864196 A,1995-08-16,Method of making a twisted optical fiber with low polarization mode dispersion,"A method of manufacturing an optical fiber, whereby a fiber is drawn from a molten extremity of a preform and is subsequently subjected to a torque, thereby causing a portion of the fiber to be twisted about its longitudinal axis and to be endowed with a spin. The torque is applied by running the fiber between a pair of wheels which rotate in mutually opposite senses about two different rotational axes, each wheel having a peripheral curved surface, the wheels being thus arranged that the fiber runs substantially tangential to their curved surfaces and is pressed therebetween, the wheels being moved back and forth relative to one another in a direction substantially perpendicular to the fiber so as to cause the fiber to be rolled back and forth between their curved surfaces.",PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT E M,DRAKA COMTEQ B.V (2007-08-02),https://lens.org/174-892-660-927-757,Granted Patent,yes,15,49,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,C03B37/027;;G02B6/02;;C03B37/03;;G02B6/00,385/123;;385/11;;385/128;;385/104,1,1,057-470-096-808-770,10.1109/50.7889,"C.G. Askins et al. Technique for Controlling the Internal Rotation of Principal Axes in the Fabrication of Birefringent Fibers , IEEE Journal of Lightwave Technology , 6 (9): 1402 1405, Sep. 1998.",EXPIRED
43,US,A1,US 2021/0371445 A1,189-500-380-837-06X,2021-12-02,2021,US 202117404695 A,2021-08-17,US 202117404695 A;;US 201815742355 A;;EP 2016066443 W;;US 201562191023 P,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises kaurenoic acid in an amount of no more than 150 ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0 or below. The invention also relates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises kaurenoic acid; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0, thereby to reduce the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,DSM IP ASSETS B.V (2017-12-15),https://lens.org/189-500-380-837-06X,Patent Application,yes,0,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H15/256;;A23L27/30;;C07H1/06,,0,0,,,,DISCONTINUED
44,CN,A,CN 1448738 A,066-596-073-919-611,2003-10-15,2003,CN 03107636 A,2003-03-20,EP 95202216 A,1995-08-16,Optical fibre with low polarisation mode dispersion,,PLASMA OPTICAL FIBRE BV,MARIE GEERTMAN ROBERT EUGENIO,"DRAKA COMMUNICATIONS TECHNOLOGY CO., LTD. (2008-03-07)",https://lens.org/066-596-073-919-611,Patent Application,no,0,0,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,G02B6/02;;C03B37/027;;C03B37/03;;G02B6/00,,0,0,,,,EXPIRED
45,DE,T2,DE 69600288 T2,123-461-300-901-698,1998-12-03,1998,DE 69600288 T,1996-01-25,EP 95200239 A;;IB 9600060 W,1995-02-01,OPTISCHE FASER MIT VERRINGERTER POLARISATIONSMODENDISPERSION,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,,https://lens.org/123-461-300-901-698,Granted Patent,no,0,0,10,10,0,C03B37/027;;C03B37/027;;C03B2203/18;;C03B2203/18;;C03B2203/36;;C03B2203/36;;C03B2205/20;;C03B2205/20;;C03C25/12;;C03C25/12;;C03C25/6208;;C03C25/6208;;C03C25/6226;;C03C25/6226;;G02B6/02147;;G02B6/02147;;G02B6/02085;;G02B6/02085;;G02B6/021;;G02B6/021;;G02B6/02109;;G02B6/02109;;G02B6/02285;;G02B6/02285;;G02B2006/02157;;G02B2006/02157,G02B6/02;;C03B37/027;;C03B37/10;;C03B37/12;;C03C25/00;;C03C25/12;;C03C25/62;;C03C25/6208;;C03C25/6226,,0,0,,,,EXPIRED
46,EP,B1,EP 0785913 B1,132-974-298-048-930,2000-05-31,2000,EP 96929243 A,1996-08-12,EP 96929243 A;;EP 9603566 W;;EP 95202216 A,1995-08-16,OPTICAL FIBER WITH LOW POLARISATION MODE DISPERSION,,PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,"DRAKA COMTEQ B.V. (2012-02-29);;DRAKA COMTEQ B.V., NL (2012-03-08)",https://lens.org/132-974-298-048-930,Granted Patent,yes,1,3,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,C03B37/027;;C03B37/03;;G02B6/02;;G02B6/00,,0,0,,,,EXPIRED
47,WO,A1,WO 1997/007067 A1,029-512-746-979-641,1997-02-27,1997,EP 9603566 W,1996-08-12,EP 95202216 A,1995-08-16,OPTICAL FIBER WITH LOW POLARISATION MODE DISPERSION,"A method of manufacturing an optical fiber, whereby a fiber (7) is drawn from a molten extremity (3) of a preform (1) and is subsequently subjected to a torque, thereby causing a portion of the fiber to be twisted about its longitudinal axis and to be endowed with a spin, whereby the torque is applied by running the fiber (7) between a pair of wheels (11a, 11b) which rotate in mutually opposite senses about two different rotational axes (13a, 13b), each wheel (11a, 11b) having a peripheral curved surface (15a, 15b), the wheels (11a, 11b) being thus arranged that the fiber (7) runs substantially tangential to their curved surfaces (15a, 15b) and is pressed therebetween, the wheels (11a, 11b) being moved back and forth relative to one another in a direction (d, d') substantially perpendicular to the fiber (7) so as to cause the fiber (7) to be rolled back and forth between their curved surfaces (15a, 15b).",PLASMA OPTICAL FIBRE BV,GEERTMAN ROBERT EUGENIO MARIE,,https://lens.org/029-512-746-979-641,Patent Application,yes,1,17,13,13,0,C03B37/02745;;C03B37/032;;C03B2203/06;;C03B2203/20;;C03B2203/36;;C03B2205/06;;G02B6/02285;;G02B6/03622;;G02B6/02285;;C03B37/032;;C03B2203/36;;C03B37/02745;;G02B6/03622;;C03B2203/06;;C03B2205/06;;C03B2203/20,C03B37/027;;C03B37/03;;G02B6/02;;G02B6/00,G2J JGF           JGF;;G2J JGFX          JGFX,1,1,057-470-096-808-770,10.1109/50.7889,"C.G.ASKINS ET AL.: ""Technique for Controlling the Internal Rotation of Pricipal Axes in the Fabrication of Birefringent Fibers"", JOURNAL OF LIGHTWAVE TECHNOLOGY, vol. 6, no. 9, September 1988 (1988-09-01), NEW YORK US, pages 1402 - 1405, XP000051357",PATENTED
48,BR,B1,BR 112018000298 B1,000-174-479-612-332,2022-06-07,2022,BR 112018000298 A,2016-07-11,EP 2016066443 W;;US 201562191023 P,2015-07-10,Método para reduzir o teor de ácido caurenóico de uma composição de glicosídeo de esteviol,"composição de glicosídeo de esteviol. a presente invenção se refere a uma composição que compreende um ou mais glicosídeos de esteviol cuja composição compreende ácido caurenóico em uma quantidade de não mais que 150 ppm. a invenção também se refere a um método para preparar uma composição de glicosídeo de esteviol, em que o método compreende: fornecer uma composição de glicosídeo de esteviol; combinar a composição de glicosídeo de esteviol com um solvente para formar uma solução de glicosídeo de esteviol; e cristalizar uma composição de glicosídeo de esteviol a partir da solução de glicosídeo de esteviol, em que a cristalização é executada no ph 7,0 ou abaixo. a invenção também se refere a um método para reduzir o teor de ácido caurenóico de uma composição de glicosídeo de esteviol, cujo método compreende: fornecer uma composição de glicosídeo de esteviol que compreende ácido caurenóico; combinar a composição de glicosídeo de esteviol com um solvente para formar uma solução de glicosídeo de esteviol; e cristalizar uma composição de glicosídeo de esteviol a partir da solução de glicosídeo de esteviol, em que a cristalização é executada no ph 7,0, para reduzir, através disso, a quantidade de ácido caurenóico na composição de glicosídeo de esteviol.",DSM IP ASSETS BV,GALAEV IGOR;;GEERTMAN ROBERT,,https://lens.org/000-174-479-612-332,Granted Patent,no,0,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;A23L27/30;;C12N15/82;;C12P19/44,,0,0,,,,ACTIVE
49,CN,A,CN 107849081 A,037-796-688-512-935,2018-03-27,2018,CN 201680040030 A,2016-07-11,US 201562191023 P;;EP 2016066443 W,2015-07-10,Steviol glycoside composition,"The present invention relates to a composition comprising one or more steviol glycosides. The composition comprises kaurenoic acid in an amount of no more than 150 ppm. The invention also relates to amethod for preparing a steviol glycoside composition, and the method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviolglycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at a pH value of 7.0 or below. The invention alsorelates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, and the method comprises: providing a steviol glycoside composition which comprises the kaurenoic acid;combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at a pH value of 7.0, thereby reducing the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/037-796-688-512-935,Patent Application,no,6,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;A23L27/30;;C12N15/82;;C12P19/44,,0,0,,,,ACTIVE
50,WO,A1,WO 2017/009294 A1,099-873-187-442-823,2017-01-19,2017,EP 2016066444 W,2016-07-11,US 201562191007 P,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/099-873-187-442-823,Patent Application,yes,22,6,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/44;;A23L27/30;;C12N15/82,,10,4,020-808-899-878-695;;063-770-860-805-05X;;099-845-086-004-957;;038-063-517-554-83X,10.1093/chromsci/35.9.446;;16786291;;10.1007/s11103-005-5966-9;;10.1016/j.jplph.2011.01.030;;21477883;;10.1021/ac60182a815,"YOHANES MARTONO ET AL.: ""Water-based crystallization and formulation of Stevioside from Stevia rebaudiana (Bert.) as natural sweetener with antidiabetic activity"", December 2012 (2012-12-01), pages 1 - 8, XP002760704, Retrieved from the Internet <URL:http://ris.uksw.edu/download/makalah/kode/M00752> [retrieved on 20160810];;ANONYMOUS: ""Manufacturing of our products"", 19 January 2012 (2012-01-19), pages 1 - 2, XP002760705, Retrieved from the Internet <URL:http://web.archive.org/web/20120119233148/http://en.sucrevia.com/stevia/why-our-stevia-products.html> [retrieved on 20160810];;DATABASE WPI Week 201213, Derwent World Patents Index; AN 2011-Q34574, XP002702395;;J. LIU ET AL: ""Subcritical Fluid Extraction of Stevia Sweeteners from Stevia rebaudiana"", JOURNAL OF CHROMATOGRAPHIC SCIENCE, vol. 35, no. 9, 1 September 1997 (1997-09-01), Cary, NC, USA, pages 446 - 450, XP055294767, ISSN: 0021-9665, DOI: 10.1093/chromsci/35.9.446;;BHARAT PARASHAR ET AL: ""Stevia (Meethi patti): Prospects As An Emerging Natural Sweetener"", 1 March 2013 (2013-03-01), pages 214 - 225, XP055294778, ISSN: 2277-5005, Retrieved from the Internet <URL:http://www.ijpcsonline.com/files/31-374.pdf> [retrieved on 20160810];;HUMPHREY ET AL., PLANT MOLECULAR BIOLOGY, vol. 61, 2006, pages 47 - 62;;MOHAMED ET AL., J. PLANT PHYSIOLOGY, vol. 168, 2011, pages 1136 - 1141;;ALEXOPOULOS, C. J.: ""Introductory Mycology"", 1962, JOHN WILEY & SONS, INC.;;SAMBROOK; RUSSEL: ""Molecular Cloning: A Laboratory Manual (3rd edition),"", 2001, COLD SPRING HARBOR LABORATORY PRESS;;F. AUSUBEL ET AL,: ""Current protocols in molecular biology"", 1987, GREEN PUBLISHING AND WILEY INTERSCIENCE",PENDING
51,CA,A1,CA 2991662 A1,124-788-545-811-659,2017-01-19,2017,CA 2991662 A,2016-07-11,US 201562191023 P;;EP 2016066443 W,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises kaurenoic acid in an amount of no more than 150ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0 or below. The invention also relates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises kaurenoic acid; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0, thereby to reduce the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSESTS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/124-788-545-811-659,Patent Application,no,0,0,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;A23L27/30;;C12N15/82;;C12P19/44,,0,0,,,,PENDING
52,WO,A1,WO 2017/009293 A1,123-589-437-110-005,2017-01-19,2017,EP 2016066443 W,2016-07-11,US 201562191023 P,2015-07-10,STEVIOL GLYCOSIDE COMPOSITION,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises kaurenoic acid in an amount of no more than 150ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0 or below. The invention also relates to a method for reducing the kaurenoic acid content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises kaurenoic acid; combining the steviol glycoside composition with a solvent to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the steviol glycoside solution, wherein the crystallization is carried out at pH7.0, thereby to reduce the amount of kaurenoic acid in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,,https://lens.org/123-589-437-110-005,Patent Application,yes,5,6,11,11,0,A23L27/30;;A23L27/36;;C07H15/256;;C07H1/06;;A23L27/36;;A23L27/30;;C07H15/256;;A23V2002/00;;C07H1/06,C07H1/08;;A23L27/30;;C12N15/82;;C12P19/44,,4,2,063-770-860-805-05X;;012-589-427-993-866,16786291;;10.1007/s11103-005-5966-9;;8806729;;10.1006/abbi.1996.0336,"YOHANES MARTONO ET AL.: ""Water-based crystallization and formulation of Stevioside from Stevia rebaudiana (Bert.) as natural sweetener with antidiabetic activity"", December 2012 (2012-12-01), pages 1 - 8, XP002760704, Retrieved from the Internet <URL:http://ris.uksw.edu/download/makalah/kode/M00752> [retrieved on 20160810];;DATABASE WPI Week 198145, Derwent World Patents Index; AN 1981-82358D, XP002469090;;HUMPHREY T V ET AL: ""Spatial organisation of four enzymes from Stevia rebaudiana that are involved in steviol glycoside synthesis"", PLANT MOLECULAR BIOLOGY, SPRINGER, DORDRECHT, NL, vol. 61, no. 1-2, 1 May 2006 (2006-05-01), pages 47 - 62, XP002752312, ISSN: 0167-4412, DOI: 10.1007/S11103-005-5966-9;;KIM KEUN KI ET AL: ""Hydroxylation of ent-kaurenoic acid to steviol in Stevia rebaudiana Bertoni-purification and partial characterization of the enzyme"", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, ACADEMIC PRESS, US, vol. 332, no. 2, 15 August 1996 (1996-08-15), pages 223 - 230, XP002468723, ISSN: 0003-9861, DOI: 10.1006/ABBI.1996.0336",PENDING
53,US,B2,US 11066688 B2,149-477-787-618-412,2021-07-20,2021,US 201615742561 A,2016-07-11,US 201615742561 A;;US 201562191007 P;;EP 2016066444 W,2015-07-10,Method for preparing a steviol glycoside composition,"The present invention relates to a composition comprising one or more steviol glycosides which composition comprises nitrogen in an amount of no more than about 1000 ppm. The invention also relates to a method for preparing a steviol glycoside composition, which method comprises: providing a steviol glycoside composition; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution. The invention also relates to a method for reducing the nitrogen content of a steviol glycoside composition, which method comprises: providing a steviol glycoside composition which comprises nitrogen; combining the steviol glycoside composition with water to form a steviol glycoside solution; and crystallizing a steviol glycoside composition from the solution, thereby to reduce the amount of nitrogen in the steviol glycoside composition.",DSM IP ASSETS BV,GEERTMAN ROBERT;;GALAEV IGOR,DSM IP ASSETS B.V (2017-12-15),https://lens.org/149-477-787-618-412,Granted Patent,yes,14,1,12,12,0,A23L27/30;;A23L27/36;;C12P19/44;;C12P19/44;;A23L27/30;;A23L27/36;;A23L27/36;;A23L27/30;;C12P19/44;;A23L33/20;;A23L2/60;;C12P19/56,C12P19/56;;A23L2/60;;A23L27/30;;A23L33/20;;C12P19/44,,7,1,020-808-899-878-695,10.1093/chromsci/35.9.446,"Martono, Yohanes et al., “Water-based crystallization and formulation of Stevioside from Stevia rebaudiana (Bert.) as a natural sweetener with antidiabetic activity,” (Dec. 2012), XP002760704, pp. 1-8.;;Anonymous, “Manufacturing of our products,” Sucrevia, (Jan. 19, 2012), XP002760705, pp. 1-2.;;WPI / THOMSON Week 201213, 23 November 2011 Derwent World Patents Index; XP002702395, FANG Y; WAN H; XIA Y: ""Preparing rubusoside, by obtaining stevioside or Stevia rebaudiana extract, preparing reaction liquor, adding beta-galactosidase to preserved material, inactivating enzyme, and concentrating, re-crystallizing and purifying product"";;J. LIU, C. P. ONG, S. F. Y. LI: ""Subcritical Fluid Extraction of Stevia Sweeteners from Stevia rebaudiana"", JOURNAL OF CHROMATOGRAPHIC SCIENCE, OXFORD UNIVERSITY PRESS, CARY, NC, USA, vol. 35, no. 9, 1 September 1997 (1997-09-01), Cary, NC, USA, pages 446 - 450, XP055294767, ISSN: 0021-9665, DOI: 10.1093/chromsci/35.9.446;;Parashar, Bharat et al., “Stevia (Meethi patti): Prospects As an Emerging Natural Sweetener,” International Journal of Pharmaceutical and Chemical Sciences, (Mar. 1, 2013), XP055294778, pp. 214-225.;;International Search Report in corresponding application No. PCT/EP2016/066444 dated Aug. 30, 2016.;;Third Party Observation of European Patent Application No. 20160738144 dated Sep. 2019.",ACTIVE
54,US,A1,US 2016/0159657 A1,045-010-569-168-476,2016-06-09,2016,US 201414899579 A,2014-06-20,EP 13173325 A;;EP 2014062987 W,2013-06-24,PROCESS AND APPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: (a) feeding to a first group of crystallization sections, which crystallization sections are heat integrated in series, a first aqueous ammonium sulfate solution that contains one or more impurities;(b) feeding to a second group of crystallization sections, which crystallization sections are heat integrated in series, a second aqueous ammonium sulfate solution that contains one or more impurities;(c) crystallizing ammonium sulfate crystals in each crystallization section respectively from each of said solutions of ammonium sulfate that contain one or more impurities;(d) purging a fraction of the ammonium sulfate solution that contains one or more impurities from each of said crystallization sections; and(e) discharging ammonium sulfate crystals from each crystallization section, characterized in that: (i) both the first group of crystallization sections and the second group of crystallization sections are together heat integrated in one series of crystallization sections; wherein the first group of crystallization sections operates at higher temperature than the second group of crystallization sections; and(ii) the composition of the first aqueous ammonium sulfate solution that contains one or more impurities is different to the composition of the second aqueous ammonium sulfate solution that contains one or more impurities. Further provided is apparatus suitable for producing ammonium sulfate crystals.",CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,CAP III B.V (2015-07-31),https://lens.org/045-010-569-168-476,Patent Application,yes,0,3,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,B01D9/00;;C01C1/24,,0,0,,,,ACTIVE
55,US,B2,US 9908785 B2,048-233-128-497-992,2018-03-06,2018,US 201414899579 A,2014-06-20,EP 13173325 A;;EP 2014062987 W,2013-06-24,Process and apparatus for producing ammonium sulfate crystals,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: (a) feeding to a first group of crystallization sections, which crystallization sections are heat integrated in series, a first aqueous ammonium sulfate solution that contains one or more impurities;(b) feeding to a second group of crystallization sections, which crystallization sections are heat integrated in series, a second aqueous ammonium sulfate solution that contains one or more impurities;(c) crystallizing ammonium sulfate crystals in each crystallization section respectively from each of said solutions of ammonium sulfate that contain one or more impurities;(d) purging a fraction of the ammonium sulfate solution that contains one or more impurities from each of said crystallization sections; and(e) discharging ammonium sulfate crystals from each crystallization section, characterized in that: (i) both the first group of crystallization sections and the second group of crystallization sections are together heat integrated in one series of crystallization sections; wherein the first group of crystallization sections operates at higher temperature than the second group of crystallization sections; and(ii) the composition of the first aqueous ammonium sulfate solution that contains one or more impurities is different to the composition of the second aqueous ammonium sulfate solution that contains one or more impurities. Further provided is apparatus suitable for producing ammonium sulfate crystals.",CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,CAP III B.V (2015-07-31),https://lens.org/048-233-128-497-992,Granted Patent,yes,4,0,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,B01D9/00;;C01C1/24;;C01C1/248;;C07C249/08;;C07D201/04;;C07D201/16,,2,0,,,"International Search Report for PCT/EP2014/062987 dated Oct. 21, 2014.;;Kawakami, Tadao, “Industrial application of nonaqueous solution chemistry”, Chemical Engineering, vol. 23, No. 2, 1959, p. 45.",ACTIVE
56,EP,A1,EP 3013748 A1,125-546-908-521-074,2016-05-04,2016,EP 14738414 A,2014-06-20,EP 13173325 A;;EP 2014062987 W;;EP 14738414 A,2013-06-24,PROCESS AND APPPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,,CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,CAP III B.V. (2017-10-25),https://lens.org/125-546-908-521-074,Patent Application,yes,0,0,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,C01C1/24;;B01D9/00;;C01C1/248;;C07C249/14;;C07D201/16,,0,0,,,,ACTIVE
57,ES,T3,ES 2733908 T3,083-466-651-843-446,2019-12-03,2019,ES 14738414 T,2014-06-20,EP 13173325 A;;EP 2014062987 W,2013-06-24,Procedimiento y aparato para producir cristales de sulfato de amonio,"Un procedimiento en continuo para producir cristales de sulfato de amonio, en el que dicho procedimiento comprende: (a) alimentar a un primer grupo de secciones de cristalización, secciones de cristalización que están integradas térmicamente en serie, una primera solución acuosa de sulfato de amonio que contiene una o más impurezas; (b) alimentar a un segundo grupo de secciones de cristalización, secciones de cristalización que están integradas térmicamente en serie, una segunda solución acuosa de sulfato de amonio que contiene una o más impurezas; (c) cristalizar cristales de sulfato de amonio en cada sección de cristalización respectivamente de cada una de dichas soluciones de sulfato de amonio que contienen una o más impurezas; (d) purgar una fracción de la solución de sulfato de amonio que contiene una o más impurezas de cada una de dichas secciones de cristalización; y (e) descargar cristales de sulfato de amonio de cada sección de cristalización, caracterizado por que: (i) tanto el primer grupo de secciones de cristalización como el segundo grupo de secciones de cristalización se integran conjuntamente por calor en una serie de secciones de cristalización; en donde el primer grupo de secciones de cristalización funciona a una temperatura más alta que el segundo grupo de secciones de cristalización; (ii) la composición de la primera solución acuosa de sulfato de amonio que contiene una o más impurezas es diferente a la composición de la segunda solución acuosa de sulfato de amonio que contiene una o más impurezas; y (iii) la primera solución acuosa de sulfato de amonio que contiene una o más impurezas y la segunda solución acuosa de sulfato de amonio que contiene una o más impurezas se producen cada una independientemente como un subproducto durante la producción de oxima de ciclohexanona, caprolactama o acrilonitrilo.",CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,,https://lens.org/083-466-651-843-446,Granted Patent,no,0,0,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,C01C1/24;;B01D9/00;;C01C1/248;;C07C249/14;;C07D201/16,,0,0,,,,ACTIVE
58,PL,T3,PL 3013748 T3,037-063-833-736-460,2019-10-31,2019,PL 14738414 T,2014-06-20,EP 13173325 A;;EP 14738414 A;;EP 2014062987 W,2013-06-24,PROCESS AND APPPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,,CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,,https://lens.org/037-063-833-736-460,Patent Application,no,0,0,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,C01C1/24;;B01D9/00;;C01C1/248;;C07C249/14;;C07D201/16,,0,0,,,,PENDING
59,EP,B1,EP 3013748 B1,049-921-901-642-161,2019-05-22,2019,EP 14738414 A,2014-06-20,EP 13173325 A;;EP 2014062987 W;;EP 14738414 A,2013-06-24,PROCESS AND APPPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,,CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,CAP III B.V. (2017-10-25),https://lens.org/049-921-901-642-161,Granted Patent,yes,3,0,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,C01C1/24;;B01D9/00;;C01C1/248;;C07C249/14;;C07D201/16,,0,0,,,,ACTIVE
60,WO,A1,WO 2014/206869 A1,010-530-069-491-33X,2014-12-31,2014,EP 2014062987 W,2014-06-20,EP 13173325 A,2013-06-24,PROCESS AND APPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: (a) feeding to a first group of crystallization sections, which crystallization sections are heat integrated in series, a first aqueous ammonium sulfate solution that contains one or more impurities; (b) feeding to a second group of crystallization sections, which crystallization sections are heat integrated in series, a second aqueous ammonium sulfate solution that contains one or more impurities; (c) crystallizing ammonium sulfate crystals in each crystallization section respectively from each of said solutions of ammonium sulfate that contain one or more impurities; (d) purging a fraction of the ammonium sulfate solution that contains one or more impurities from each of said crystallization sections; and (e) discharging ammonium sulfate crystals from each crystallization section, characterized in that: (i) both the first group of crystallization sections and the second group of crystallization sections are together heat integrated in one series of crystallization sections; wherein the first group of crystallization sections operates at higher temperature than the second group of crystallization sections; and (ii) the composition of the first aqueous ammonium sulfate solution that contains one or more impurities is different to the composition of the second aqueous ammonium sulfate solution that contains one or more impurities. Further provided is apparatus suitable for producing ammonium sulfate crystal.",DSM IP ASSETS BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;GEERTMAN ROBERT,,https://lens.org/010-530-069-491-33X,Patent Application,yes,8,0,7,7,0,B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;C01C1/24;;B01D9/0031;;C07D201/04;;C07C249/08;;C07C2601/14;;B01D9/0022;;B01D9/0063;;C01C1/248;;C07D201/16;;C01C1/24;;B01D9/004;;B01D2009/0086,B01D9/00;;C01C1/24;;C01C1/248;;C07C249/14;;C07D201/16,,4,2,106-989-730-471-666;;106-989-730-471-666,10.1016/0375-6505(92)90029-9;;10.1016/0375-6505(92)90029-9,"DON W. GREEN; JAMES O. MALONEY: ""Perry's Chemical Engineers Handbook"", 1997, MCGRAW HILL, pages: 44 - 55;;I. KRISTJANSSON, GEOTHERMICS, vol. 21, 1992, pages 765 - 771;;KRISTJANSSON, GEOTHERMICS, vol. 21, 1992, pages 765 - 771;;TADAO KAWAKAMI: ""Industrial application of nonaqueous solution chemistry"", CHEMICAL ENGINEERING, vol. 23, no. 2, 1959, pages 106 (42) - 112 (48), XP055411853",PENDING
61,WO,A1,WO 2020/169736 A1,071-117-704-868-137,2020-08-27,2020,EP 2020054485 W,2020-02-20,CN 2019075834 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE","The present invention relates to a crystalline form of 1-(1-oxo-1,2- dihydroisoquinolin-5-yl)-5-(trifluoromethyl)- N -[2-(trifluoromethyl) pyridin-4-yl]-1 H -pyrazole-4-carboxamide (Compound A) monohydrate and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV;;JOHNSON & JOHNSON CHINA INVEST LTD,LEYS CARINA;;KIMPE KRISTOF;;GEERTMAN ROBERT;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/071-117-704-868-137,Patent Application,yes,2,6,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,A61K31/4725;;C07D401/14;;A61P35/00;;A61P35/02,,20,11,104-949-654-022-72X;;001-676-197-805-749;;088-303-580-091-034;;105-129-409-527-399;;015-845-506-559-143;;087-192-267-012-779;;001-676-197-805-749;;078-519-855-308-942;;016-279-471-633-683;;149-087-447-664-064;;047-138-645-820-688,10.1007/3-540-69178-2_5;;pmc4713714;;10.1007/s00018-015-2059-z;;26507244;;10.1111/j.1600-065x.2012.01105.x;;pmc4094296;;22435566;;26787500;;10.1016/j.molmed.2015.12.004;;10.4331/wjbc.v7.i1.128;;26981201;;pmc4768116;;10.1126/science.1198946;;21273489;;pmc3124150;;pmc4713714;;10.1007/s00018-015-2059-z;;26507244;;pmc4112826;;10.1186/1742-2094-11-124;;25043939;;10.1016/j.jaci.2013.10.045;;24332264;;pmc3700575;;23727036;;10.1016/j.jaci.2013.04.047;;pmc4352191;;25627829;;10.1007/s10875-014-0125-1,"MINO R CAIRA ED - MONTCHAMP JEAN-LUC: ""CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS"", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, [retrieved on 19990226], DOI: 10.1007/3-540-69178-2_5;;JAWORSKI ET AL., CELL MOL LIFE SCIENCE, vol. 73, 2016, pages 459 - 473;;STAUDT, COLD SPRING HARB PERSPECT BIOL, 2010, pages 2;;LIM ET AL., IMMUNOL REV, vol. 246, 2012, pages 359 - 378;;FONTAN ET AL., CANCER CELL, vol. 22, 2012, pages 825 - 837;;DEMEYER ET AL., TRENDS MOL MED, vol. 22, 2016, pages 135 - 150;;ROSEBECK ET AL., WORLD J BIOL CHEM, vol. 7, 2016, pages 128 - 137;;ROSEBECK ET AL., SCIENCE, vol. 331, 2011, pages 468 - 472;;JAWORSKI M ET AL., CELL MOL LIFE SCI., 2016;;MC GUIRE ET AL., J. NEUROINFLAMMATION, vol. 11, 2014, pages 124;;JAWORSKI ET AL., EMBO J., 2014;;GEWIES ET AL., CELL REPORTS, 2014;;BORNANCIN ET AL., J. IMMUNOLOGY, 2015;;YU ET AL., PLOS ONE, 2015;;MCKINNON ET AL., J. ALLERGY CLIN. IMMUNOL., vol. 133, 2014, pages 1458 - 1462;;JABARA ET AL., J. ALLERGY CLIN. IMMUNOL., vol. 132, 2013, pages 151 - 158;;PUNWANI ET AL., J. CLIN. IMMUNOL., vol. 35, 2015, pages 135 - 146;;ICH HARMONISED TRIPARTITE GUIDELINE, STABILITY TESTING: PHOTOSTABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS, QIB, November 1996 (1996-11-01);;PHARMACOPEIAL FORUM, vol. 38, no. 1;;""European Pharmacopeia""",PENDING
62,HU,A,HU T66949 A,152-615-695-506-019,1995-01-30,1995,HU 9200585 A,1992-02-21,NL 9100335 A,1991-02-26,METHOD OF MANUFACTURING TUBE GLASS,,PHILIPS NV,VERSPUI GERRIT;;GEERTMAN ROBERT EUGENIO MARIE;;DAMSTEEGT JOHANNES ARIE GIJSBE,,https://lens.org/152-615-695-506-019,Unknown,no,0,0,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,,0,0,,,,DISCONTINUED
63,DE,D1,DE 69201380 D1,179-879-426-595-024,1995-03-23,1995,DE 69201380 T,1992-02-18,NL 9100335 A,1991-02-26,Verfahren zum Herstellen von Rohrglas.,,PHILIPS ELECTRONICS NV,GEERTMAN ROBERT EUGENIO MARIE;;VERSPUI GERRIT;;DAMSTEEGT JOHANNES ARIE GIJSBE,,https://lens.org/179-879-426-595-024,Granted Patent,no,0,0,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,,0,0,,,,EXPIRED
64,SG,A,SG 11202108909S A,150-475-439-333-660,2021-09-29,2021,SG 11202108909S A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE",,JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF;;GEERTMAN ROBERT;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/150-475-439-333-660,Unknown,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
65,HU,D0,HU 9200585 D0,172-158-152-006-311,1992-06-29,1992,HU 9200585 A,1992-02-21,NL 9100335 A,1991-02-26,METHOD FOR MANUFACTURING GLASS TUBE,,PHILIPS NV,GEERTMAN ROBERT EUGENIO MARIE;;DAMSTEEGT JOHANNES ARIE GIJSBE;;VERSPUI GERRIT,,https://lens.org/172-158-152-006-311,Patent Application,no,0,0,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,,0,0,,,,DISCONTINUED
66,DE,T2,DE 69201380 T2,080-380-781-849-532,1995-09-14,1995,DE 69201380 T,1992-02-18,NL 9100335 A,1991-02-26,Verfahren zum Herstellen von Rohrglas.,,PHILIPS ELECTRONICS NV,GEERTMAN ROBERT EUGENIO MARIE;;VERSPUI GERRIT;;DAMSTEEGT JOHANNES ARIE GIJSBE,,https://lens.org/080-380-781-849-532,Granted Patent,no,0,2,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,,0,0,,,,EXPIRED
67,EP,A1,EP 0501562 A1,104-036-864-216-34X,1992-09-02,1992,EP 92200460 A,1992-02-18,NL 9100335 A,1991-02-26,Method of manufacturing tube glass.,"In the manufacture of tube glass, in which following the drawing of a tube from molten glass the inside surface of the tube is treated with a chemically reactive gas or gas mixture, a gas or gas mixture which is not reactive at the drawing temperature of the glass is dispensed into the tube in the direction of drawing. At a location in the tube where the tube has cooled down so far that the diameter is constant, the gas or gas mixture is made to react by means of a plasma which is generated in the tube.",PHILIPS NV,GEERTMAN ROBERT EUGENIO MARIE;;VERSPUI GERRIT;;DAMSTEEGT JOHANNES ARIE GIJSBE,,https://lens.org/104-036-864-216-34X,Patent Application,yes,3,9,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,,1,0,,,"PHILIPS TECHNICAL REVIEW. vol. 44, no. 8-10, May 1989, EINDHOVEN NL pages 241 - 249; P.GEITTNER ET AL.: 'Manufacturing Optical Fibres By The PCVD Process.'",EXPIRED
68,EP,B1,EP 0501562 B1,140-257-905-383-510,1995-02-15,1995,EP 92200460 A,1992-02-18,NL 9100335 A,1991-02-26,Method of manufacturing tube glass.,,PHILIPS ELECTRONICS NV,GEERTMAN ROBERT EUGENIO MARIE;;VERSPUI GERRIT;;DAMSTEEGT JOHANNES ARIE GIJSBE,,https://lens.org/140-257-905-383-510,Granted Patent,yes,1,4,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,,1,0,,,P.GEITTNER ET AL.: 'Manufacturing Optical Fibres By The PCVD Process.',EXPIRED
69,UA,C2,UA 79628 C2,163-617-506-222-286,2007-07-10,2007,UA 2005002038 A,2003-07-16,US 40202002 P;;EP 0307692 W,2002-08-08,EVAPORATIVE CRYSTALLISATION PROCESS FOR OBTAINING SALT COMPOSITIONS AND USE THEREOF IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/163-617-506-222-286,Limited Patent,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/00;;C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
70,PL,A1,PL 373869 A1,054-353-910-394-487,2005-09-19,2005,PL 37386903 A,2003-07-16,US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/054-353-910-394-487,Patent Application,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,DISCONTINUED
71,CN,A,CN 1674966 A,000-215-365-025-293,2005-09-28,2005,CN 03818991 A,2003-07-16,US 40202002 P,2002-08-08,Process to make high-purity salt and the use thereof in an electrolysis process,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,JACQUES MAYER MATEO JOZEF;;MICHAEL GEERTMAN ROBERT;;MARIA DEMMER RENE LODEWIJK,,https://lens.org/000-215-365-025-293,Patent Application,no,0,5,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,DISCONTINUED
72,AU,A1,AU 2003/250964 A1,045-436-151-355-029,2004-03-11,2004,AU 2003/250964 A,2003-07-16,EP 0307692 W;;US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,,AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/045-436-151-355-029,Patent Application,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,DISCONTINUED
73,EA,B1,EA 007045 B1,029-048-140-948-983,2006-06-30,2006,EA 200500324 A,2003-07-16,US 40202002 P;;EP 0307692 W,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SOand/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOSEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/029-048-140-948-983,Granted Patent,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,B01D9/00;;C01D3/14;;C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
74,US,A1,US 2005/0076477 A1,063-621-432-137-033,2005-04-14,2005,US 62357403 A,2003-07-22,US 62357403 A;;US 40202002 P,2002-08-08,"Process to make high-purity salt or wet salt, salt SO obtainable, and the use thereof in an electrolysis process","The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO 4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,AKZO NOBEL N.V (2003-09-16),https://lens.org/063-621-432-137-033,Patent Application,yes,12,6,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,0233,0,0,,,,DISCONTINUED
75,BR,A,BR 0313468 A,162-445-000-505-639,2005-07-05,2005,BR 0313468 A,2003-07-16,EP 0307692 W;;US 40202002 P,2002-08-08,Processo para fabricar sal de alta pureza e seu uso em processos eletrolìticos,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/162-445-000-505-639,Patent Application,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,DISCONTINUED
76,EP,A1,EP 1545733 A1,022-379-014-510-990,2005-06-29,2005,EP 03792202 A,2003-07-16,EP 0307692 W;;US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/022-379-014-510-990,Patent Application,yes,0,2,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
77,DK,T3,DK 1545733 T3,100-682-778-549-181,2007-04-02,2007,DK 03792202 T,2003-07-16,US 40202002 P;;EP 0307692 W,2002-08-08,Fremgangsmåde til fremstilling af höjrent salt og anvendelse deraf i elektrolyseprocesser,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,DEMMER RENE LODEWIJK MARIA;;MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL,,https://lens.org/100-682-778-549-181,Granted Patent,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,B01D9/00;;C01D3/14;;C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
78,NO,L,NO 20050451 L,179-206-013-749-746,2005-03-04,2005,NO 20050451 A,2005-01-26,US 40202002 P;;EP 0307692 W,2002-08-08,Fremgangsmate for fremstilling av salt med hoy renhet og anvendelse derav i elektrolyse prosesser,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,DEMMER RENE LODEWIJK MARIA;;MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL,,https://lens.org/179-206-013-749-746,Abstract,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,DISCONTINUED
79,EP,B1,EP 1545733 B1,192-977-243-971-824,2007-01-03,2007,EP 03792202 A,2003-07-16,EP 0307692 W;;US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/192-977-243-971-824,Granted Patent,yes,3,2,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,B01D9/00;;C01D3/14;;C01D3/16;;C01D3/24;;C01D3/26,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 402 (C-633), 6 September 1989 (1989-09-06) & JP 01 145320 A (JAPAN TOBACCO INC), 7 June 1989 (1989-06-07)",EXPIRED
80,PT,E,PT 1545733 E,178-580-945-430-632,2007-02-28,2007,PT 03792202 T,2003-07-16,US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL;;MAYER MATEO JOZEF JACQUES;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/178-580-945-430-632,Granted Patent,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,B01D9/00;;C01D3/14;;C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
81,WO,A1,WO 2004/018068 A1,029-197-101-097-45X,2004-03-04,2004,EP 0307692 W,2003-07-16,US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/029-197-101-097-45X,Patent Application,yes,3,8,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 402 (C - 633) 6 September 1989 (1989-09-06)",PATENTED
82,TW,A,TW 200404745 A,124-001-669-585-532,2004-04-01,2004,TW 92121649 A,2003-08-07,US 40202002 P,2002-08-08,"Process to make high-purity salt or wet salt, salt so obtainable, and the use thereof in an electrolysis process","The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/124-001-669-585-532,Patent of Addition,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/22;;C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,PENDING
83,ES,T3,ES 2279216 T3,095-758-374-313-825,2007-08-16,2007,ES 03792202 T,2003-07-16,US 40202002 P,2002-08-08,PROCEDIMIENTO PARA FABRICAR SAL DE GRAN PUREZA Y SU USO EN PROCESOS DE ELECTROLISIS.,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/095-758-374-313-825,Granted Patent,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,B01D9/00;;C01D3/14;;C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
84,CA,A1,CA 2495543 A1,117-522-811-420-289,2004-03-04,2004,CA 2495543 A,2003-07-16,EP 0307692 W;;US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSISPROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,DEMMER RENE LODEWIJK MARIA;;MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL,,https://lens.org/117-522-811-420-289,Patent Application,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,DISCONTINUED
85,AT,T1,AT E350122 T1,190-431-531-360-908,2007-01-15,2007,AT 03792202 T,2003-07-16,US 40202002 P,2002-08-08,VERFAHREN ZUR HERSTELLUNG VON HOCHREINEM SALZ UND SEINE VERWENDUNG IN ELEKTROLYSEVERFAHREN,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/190-431-531-360-908,Granted Patent,no,0,0,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,C01D3/16;;C01D3/24;;C01D3/26,,0,0,,,,EXPIRED
86,EP,B9,EP 1545733 B9,006-192-563-217-279,2007-05-30,2007,EP 03792202 A,2003-07-16,EP 0307692 W;;US 40202002 P,2002-08-08,PROCESS TO MAKE HIGH-PURITY SALT AND ITS USE IN ELECTROLYSIS PROCESSES,"The invention relates to an evaporative crystallisation process to make salt compositions which includes a step wherein a mother liquor containing an effective amount of a crystal growth comprising at least one saccharide or saccharide derivative is formed, to form high-purity salt. The salt can be washed with a reduced amount of washing water while still containing lower amounts of K, Br, SO4 and/or Ca. The high-purity salt can be obtained after drying of the salt crystals formed. A wet salt can be obtained by partially drying said salt crystals.",AKZO NOBEL NV,MAYER MATEO JOZEF JACQUES;;GEERTMAN ROBERT MICHAEL;;DEMMER RENE LODEWIJK MARIA,,https://lens.org/006-192-563-217-279,Amended Patent,yes,3,1,22,22,0,C01D3/16;;C01D3/24;;C01D3/26;;C01D3/26;;C01D3/16;;C01D3/24,B01D9/00;;C01D3/14;;C01D3/16;;C01D3/24;;C01D3/26,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 402 (C-633), 6 September 1989 (1989-09-06) & JP 01 145320 A (JAPAN TOBACCO INC), 7 June 1989 (1989-06-07)",EXPIRED
87,US,A,US 5213599 A,099-129-334-856-538,1993-05-25,1993,US 83838692 A,1992-02-19,NL 9100335 A,1991-02-26,METHOD OF MANUFACTURING TUBE GLASS,"In the manufacture of tube glass, in which following the drawing of a tube from molten glass the inside surface of the tube is treated with a chemically reactive gas or gas mixture, a gas or gas mixture which is not reactive at the drawing temperature of the glass is dispensed into the tube in the direction of drawing. At a location in the tube where the tube has cooled down so far that the diameter is constant, the gas or gas mixture is made to react by means of a plasma which is generated in the tube.",PHILIPS CORP,GEERTMAN ROBERT E M;;VERSPUI GERRIT;;DAMSTEEGT JOHANNES A G P,U.S. PHILIPS CORPORATION A CORPORATION OF DELAWARE (1992-03-31),https://lens.org/099-129-334-856-538,Granted Patent,yes,5,10,9,9,0,C03B17/04;;C03C15/00;;C03C17/004;;C03C17/245;;Y10S65/04;;C03C17/245;;C03C15/00;;C03C17/004;;C03B17/04;;Y10S65/04,C03B17/04;;C03C15/00;;C03C17/00;;C03C17/245,65/30.1;;65/31;;65/60.1;;65/86;;65/126;;X 65DIG 4;;427/237,1,0,,,"Philips Tech. Review No. 44, pp. 241 249 May 1989 Manufacturing Optical Fibres by the PCVD Process Geittenr et al.",EXPIRED
88,CA,A1,CA 3129623 A1,001-811-219-621-633,2020-08-27,2020,CA 3129623 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE","The present invention relates to a crystalline form of 1-(1-oxo-1,2- dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl) pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A) monohydrate and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/001-811-219-621-633,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
89,EP,C0,EP 3927696 C0,045-065-583-183-400,2023-10-18,2023,EP 20707585 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE",,JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/045-065-583-183-400,Unknown,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,ACTIVE
90,EC,A,EC SP21067828 A,082-946-230-436-638,2021-11-18,2021,EC DI202167828 A,2021-09-14,CN 2019075834 W,2019-02-22,"FORMA CRISTALINA DE 1-(1-OXO-1,2-DIHIDROISOQUINOLIN-5-IL)-5-(TRIFLUOROMETIL)-N-(2-(TRIFLUOROMETIL)PIRIDIN-4-IL)-1H-PIRAZOL-4-CARBOXAMIDA MONOHIDRATADA","La presente invención se refiere a una forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifluorometil)-N-[2-(trifluorometil)piridin-4-il]-1H-pirazol-4-carboxamida (Compuesto A) monohidratada y a procesos para la preparación de esta. La forma cristalina y las composiciones de esta son útiles en el tratamiento de las enfermedades relacionadas con MALT-1.",JANSSEN PHARMACEUTICA NV,WEI HAOJUAN;;KIMPE KRISTOF LEONARD;;ZHOU PENG;;LEYS CARINA;;GEERTMAN ROBERT MICHAEL,,https://lens.org/082-946-230-436-638,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
91,EP,A1,EP 3927696 A1,016-924-295-401-371,2021-12-29,2021,EP 20707585 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE",,JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/016-924-295-401-371,Patent Application,yes,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,ACTIVE
92,EP,B1,EP 3927696 B1,035-772-651-586-114,2023-10-18,2023,EP 20707585 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE",,JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/035-772-651-586-114,Granted Patent,yes,1,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,1,0,,,"MINO R CAIRA ED - MONTCHAMP JEAN-LUC: ""CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS"", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163-208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5 [retrieved on 1999-02-26]",ACTIVE
93,UY,A,UY 38592 A,049-800-062-472-85X,2020-08-31,2020,UY 38592 A,2020-02-21,CN 2019075834 W,2019-02-22,"FORMA CRISTALINA DE 1-(1-OXO-1,2-DIHIDROISOQUINOLIN-5-IL)-5-(TRIFLUOROMETIL)-N-(2-(TRIFLUOROMETIL)PIRIDIN-4-IL)-1H-PIRAZOL-4-CARBOXAMIDA MONOHIDRATADA, PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN","Se divulga una forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5-(trifluorometil)-N-[2-(trifluorometil)piridin-4-il]-1H-pirazol-4-carboxamida (Compuesto A) monohidratada y a procesos para la preparación de esta. La forma cristalina y las composiciones de esta son útiles en el tratamiento de las enfermedades relacionadas con MALT-1.",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/049-800-062-472-85X,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,A61P35/00;;A61K31/4725;;A61P37/00;;C07D401/14,,0,0,,,,PENDING
94,CN,A,CN 113474339 A,067-906-816-317-310,2021-10-01,2021,CN 202080015968 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE","The present invention relates to a crystalline form of 1-(1-oxo-1,2- dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl) pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A) monohydrate and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF L;;GEERTMAN ROBERT M;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/067-906-816-317-310,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
95,MX,A,MX 2021010133 A,103-682-202-260-018,2021-09-23,2021,MX 2021010133 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIF LUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H</i >-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE.","The present invention relates to a crystalline form of 1-(1-oxo-1,2- dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifl uoromethyl) pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A) monohydrate and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV,ZHOU PENG;;LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN,,https://lens.org/103-682-202-260-018,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14,,0,0,,,,PENDING
96,MA,A,MA 55019 A,121-039-704-401-802,2021-12-29,2021,MA 55019 A,2020-02-20,CN 2019075834 W,2019-02-22,"FORME CRISTALLINE DU MONOHYDRATE DE 1-(1-OXO-1,2-DIHYDROISOQUINOLÉIN-5-YL)-5-(TRIFLUOROMÉTHYL)-(2-(TRIFLUOROMÉTHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE",,JANSSEN PHARMACEUTICA NV,GEERTMAN ROBERT MICHAEL;;KIMPE KRISTOF LEONARD;;LEYS CARINA;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/121-039-704-401-802,Unknown,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14,,0,0,,,,PENDING
97,PE,A1,PE 20212067 A1,089-225-980-099-778,2021-10-26,2021,PE 2021001372 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"FORMA CRISTALINA DE 1-(1-OXO-1,2-DIHIDROISOQUINOLIN-5-IL)-5-(TRIFLUOROMETIL)-N-(2- (TRIFLUOROMETIL)PIRIDIN-4-IL)-1H-PIRAZOL-4-CARBOXAMIDA MONOHIDRATADA","Referido a una forma cristalina de 1-(1-oxo-1,2-dihidroisoquinolin-5-il)-5- (trifluorometil)-N-[2-(trifluorometil)piridin-4-il]-1H-pirazol-4-carboxamida (Compuesto A) monohidratada, donde la forma cristalina es la Forma III, que produce un patron de difraccion de rayos X de polvo que comprende picos a 16.4, 23.7 y 25.7 grados dos theta ± 0.2 grados dos theta. Tambien se refiere a composiciones farmaceuticas; el proceso de preparacion de la forma cristalina, que comprende el paso de recristalizar el compuesto A; y a su uso en el tratamiento del cancer y enfermedades, sindromes, trastornos o afecciones autoinmunologicos asociados con inhibidores de MALT1.",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/089-225-980-099-778,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
98,US,A1,US 2022/0127249 A1,111-717-035-816-839,2022-04-28,2022,US 201917431447 A,2019-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE","The present invention relates to a crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A) monohydrate, and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,CHANGZHOU SYNTHEALL PHARMACEUTICAL CO. LTD (2021-09-13);;JANSSEN PHARMACEUTICA NV (2019-12-11);;STA PHARMACEUTICAL HONG KONG LIMITED (2019-11-25),https://lens.org/111-717-035-816-839,Patent Application,yes,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14,,0,0,,,,PENDING
99,AU,A1,AU 2020/226723 A1,002-122-101-893-943,2021-08-19,2021,AU 2020/226723 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"Crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-","The present invention relates to a crystalline form of 1-(1-oxo-1,2- dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAOJUAN;;ZHOU PENG,,https://lens.org/002-122-101-893-943,Patent Application,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
100,JO,A1,JO P20210227 A1,186-846-657-840-376,2023-01-30,2023,JO P20210227 A,2020-02-20,CN 2019075834 W;;EP 2020054485 W,2019-02-22,"CRYSTALLINE FORM OF 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBOXAMIDE MONOHYDRATE","The present invention relates to a crystalline form of 1-(1-oxo-1,2- dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl) pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A) monohydrate and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV,ZHOU PENG;;GEERTMAN ROBERT MICHAEL;;KIMPE KRISTOF LEONARD;;LEYS CARINA;;WEI HAOJUAN,,https://lens.org/186-846-657-840-376,Granted Patent,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,,,0,0,,,,ACTIVE
101,AT,T1,AT E406946 T1,044-726-406-840-86X,2008-09-15,2008,AT 04729890 T,2004-04-28,US 46676103 P,2003-04-29,"VERFAHREN ZUR VERFESTIGUNG, BEI WELCHEM EIN ANTI- LÖSUNGSMITTEL BENUTZT WIRD",,ORGANON NV,BAKKER WRIDZER;;GEERTMAN ROBERT;;REEDIJK MARIANNE;;BALTUSSEN JOZEF;;BARGEMAN GERRALD;;VAN LARE CORNELIS,,https://lens.org/044-726-406-840-86X,Granted Patent,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,INACTIVE
102,TW,A,TW 202045495 A,045-623-146-143-607,2020-12-16,2020,TW 109105620 A,2020-02-21,CN 2019075834 W,2019-02-22,"Crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrazole-4-carboxamide monohydrate","The present invention relates to a crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A) monohydrate, and processes for preparation thereof. The crystalline form and compositions thereof are useful in the treatment of MALT-1 related diseases.",JANSSEN PHARMACEUTICA NV,LEYS CARINA;;KIMPE KRISTOF LEONARD;;GEERTMAN ROBERT MICHAEL;;WEI HAO-JUAN;;ZHOU PENG,,https://lens.org/045-623-146-143-607,Patent of Addition,no,0,0,20,20,0,C07D401/14;;A61K31/4725;;A61P35/00;;A61P35/02;;A61K31/4725;;A61P35/00;;A61P35/02;;C07D401/14;;C07D401/14;;A61K31/4709;;A61P35/00;;A61P37/00;;C07B2200/13;;C07B2200/13;;C07D401/14,C07D401/14;;A61K31/4725;;A61P35/00,,0,0,,,,PENDING
103,US,A1,US 2016/0214868 A1,048-858-882-694-39X,2016-07-28,2016,US 201314649823 A,2013-11-29,EP 12195812 A;;EP 2013075087 W,2012-12-06,PROCESS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: i) feeding to a series of crystallization sections, which crystallization sections are heat integrated in series, a solution of ammonium sulfate; ii) crystallizing ammonium sulfate crystals from said solution of ammonium sulfate; iii) purging a fraction of the solution of ammonium sulfate from each of said crystallization sections;and iv) discharging ammonium sulfate crystals from each crystallization section, characterized in that: a fraction of said solution of ammonium sulfate is purged from at least one crystallization section to at least one other crystallization section; and an apparatus suitable for producing ammonium sulfate crystals.",DSM IP ASSETS BV,EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;VAN YSACKER PETER;;TINGE JOHAN THOMAS,CAP III B.V (2015-11-30);;DSM IP ASSETS B.V (2015-06-17),https://lens.org/048-858-882-694-39X,Patent Application,yes,1,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/24;;B01D9/00,,0,0,,,,ACTIVE
104,PL,T3,PL 2928828 T3,050-365-288-348-781,2017-08-31,2017,PL 13799026 T,2013-11-29,EP 12195812 A;;EP 13799026 A,2012-12-06,PROCESS AND APPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,,CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER VAN PETER,,https://lens.org/050-365-288-348-781,Patent Application,no,0,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/248;;B01D9/00;;C05C3/00,,0,0,,,,PENDING
105,TW,A,TW 201429873 A,131-953-619-783-348,2014-08-01,2014,TW 102144591 A,2013-12-05,EP 12195812 A,2012-12-06,Process for producing ammonium sulfate crystals,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: (i) feeding to a series of crystallization sections, which crystallization sections are heat integrated in series, a solution of ammonium sulfate; (ii) crystallizing ammonium sulfate crystals from said solution of ammonium sulfate; (iii) purging a fraction of the solution of ammonium sulfate from each of said crystallization sections; and (iv) discharging ammonium sulfate crystals from each crystallization section, characterized in that: a fraction of said solution of ammonium sulfate is purged from at least one crystallization section to at least one other crystallization section; and an apparatus suitable for producing ammonium sulfate crystals.",DSM IP ASSETS BV,EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER PETER VAN;;TINGE JOHAN THOMAS,,https://lens.org/131-953-619-783-348,Patent of Addition,no,0,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/20,,0,0,,,,ACTIVE
106,EP,B1,EP 2928828 B1,078-630-455-679-950,2016-10-05,2016,EP 13799026 A,2013-11-29,EP 12195812 A;;EP 2013075087 W;;EP 13799026 A,2012-12-06,PROCESS AND APPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,,CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER VAN PETER,CAP III B.V. (2016-01-06),https://lens.org/078-630-455-679-950,Granted Patent,yes,6,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/248;;B01D9/00;;C05C3/00,,1,0,,,"INGOLFUR KRISTJANSSON: ""Commercial production of salt from geothermal brine at Reykjanes, Iceland"", GEOTHERMICS, vol. 21, no. 5/6, 1 January 1992 (1992-01-01), pages 765-771, XP055051899, cited in the application",ACTIVE
107,CN,A,CN 104903236 A,138-431-192-879-952,2015-09-09,2015,CN 201380063066 A,2013-11-29,EP 2013075087 W;;EP 12195812 A,2012-12-06,process and apparatus for producing ammonium sulfate crystals,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: i)feeding to a series of crystallization sections, which crystallization sections are heat integrated in series, a solution of ammonium sulfate; ii)crystallizing ammonium sulfate crystals from said solution of ammonium sulfate; iii)purging a fraction of the solution of ammonium sulfate from each of said crystallization sections;and iv)discharging ammonium sulfate crystals from each crystallization section, characterized in that: a fraction of said solution of ammonium sulfate is purged from at least one crystallization section to at least one other crystallization section. The invention also provides an apparatus suitable for producing ammonium sulfate crystals.",DSM IP ASSETS BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER VAN PETER,,https://lens.org/138-431-192-879-952,Patent Application,no,4,3,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/248;;B01D9/00;;C05C3/00,,0,0,,,,ACTIVE
108,EP,A1,EP 2928828 A1,002-936-477-087-803,2015-10-14,2015,EP 13799026 A,2013-11-29,EP 12195812 A;;EP 2013075087 W;;EP 13799026 A,2012-12-06,PROCESS AND APPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,,DSM IP ASSETS BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER VAN PETER,CAP III B.V. (2016-01-06),https://lens.org/002-936-477-087-803,Patent Application,yes,0,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/248;;B01D9/00;;C05C3/00,,0,0,,,,ACTIVE
109,TW,B,TW I603918 B,084-017-699-880-863,2017-11-01,2017,TW 102144591 A,2013-12-05,EP 12195812 A,2012-12-06,Process for producing ammonium sulfate crystals,,CAP III BV,EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER PETER VAN;;TINGE JOHAN THOMAS,,https://lens.org/084-017-699-880-863,Granted Patent,no,6,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,,,0,0,,,,ACTIVE
110,ES,T3,ES 2609477 T3,163-497-986-448-343,2017-04-20,2017,ES 13799026 T,2013-11-29,EP 12195812 A;;EP 2013075087 W,2012-12-06,Procedimiento y aparato para producir cristales de sulfato de amonio,"Un procedimiento continuo para producir cristales de sulfato de amonio, en donde dicho procedimiento comprende: i) alimentar a una serie de secciones de cristalización, secciones de cristalización que están integradas térmicamente en serie, una solución de sulfato de amonio; ii) cristalizar cristales de sulfato de amonio a partir de dicha solución de sulfato de amonio; iii) purgar una fracción de la solución de sulfato de amonio de cada una de dichas secciones de cristalización; y iv) descargar cristales de sulfato de amonio desde cada sección de cristalización, caracterizado por que: una fracción de dicha solución de sulfato de amonio se purga desde al menos una sección de cristalización hasta al menos otra sección de cristalización.",CAP III BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER VAN PETER,,https://lens.org/163-497-986-448-343,Granted Patent,no,0,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/248;;B01D9/00;;C05C3/00,,0,0,,,,ACTIVE
111,WO,A1,WO 2014/086676 A1,001-416-147-357-81X,2014-06-12,2014,EP 2013075087 W,2013-11-29,EP 12195812 A,2012-12-06,PROCESS AND APPARATUS FOR PRODUCING AMMONIUM SULFATE CRYSTALS,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: i)feeding to a series of crystallization sections, which crystallization sections are heat integrated in series, a solution of ammonium sulfate; ii)crystallizing ammonium sulfate crystals from said solution of ammonium sulfate; iii)purging a fraction of the solution of ammonium sulfate from each of said crystallization sections;and iv)discharging ammonium sulfate crystals from each crystallization section, characterized in that: a fraction of said solution of ammonium sulfate is purged from at least one crystallization section to at least one other crystallization section; and an apparatus suitable for producing ammonium sulfate crystals.",DSM IP ASSETS BV,TINGE JOHAN THOMAS;;EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;YSACKER VAN PETER,,https://lens.org/001-416-147-357-81X,Patent Application,yes,6,0,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/248;;B01D9/00;;C05C3/00,,1,1,106-989-730-471-666,10.1016/0375-6505(92)90029-9,"INGOLFUR KRISTJANSSON: ""Commercial production of salt from geothermal brine at Reykjanes, Iceland"", GEOTHERMICS, vol. 21, no. 5/6, 1 January 1992 (1992-01-01), pages 765 - 771, XP055051899",PENDING
112,US,B2,US 10138133 B2,128-411-668-208-433,2018-11-27,2018,US 201314649823 A,2013-11-29,EP 12195812 A;;EP 2013075087 W,2012-12-06,Process for producing ammonium sulfate crystals,"The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: i) feeding to a series of crystallization sections, which crystallization sections are heat integrated in series, a solution of ammonium sulfate; ii) crystallizing ammonium sulfate crystals from said solution of ammonium sulfate; iii) purging a fraction of the solution of ammonium sulfate from each of said crystallization sections; and iv) discharging ammonium sulfate crystals from each crystallization section, characterized in that: a fraction of said solution of ammonium sulfate is purged from at least one crystallization section to at least one other crystallization section; and an apparatus suitable for producing ammonium sulfate crystals.",CAP III BV,EKKELENKAMP GEERT;;DEBEIJ JOHANNES ELISABETH PIERRE;;GEERTMAN ROBERT;;VAN YSACKER PETER;;TINGE JOHAN THOMAS,CAP III B.V (2015-11-30);;DSM IP ASSETS B.V (2015-06-17),https://lens.org/128-411-668-208-433,Granted Patent,yes,9,1,11,11,0,B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/0031;;B01D9/0036;;B01D9/0063;;C01C1/248;;C05C3/005;;C05C3/00;;B01D9/004;;B01D9/0059;;B01D2009/0086;;C01C1/24,C01C1/24;;B01D9/00;;C01C1/248;;C05C3/00,,1,1,106-989-730-471-666,10.1016/0375-6505(92)90029-9,"I. Kristjansson, “Commercial Production of Salt from Geothermal Brine at Reykjanes, Iceland”, Geothermics, vol. 21, No. 5/6, Jan. 1, 1992, pp. 765-771.",ACTIVE
113,AT,T1,AT E215909 T1,044-340-937-386-326,2002-04-15,2002,AT 98966423 T,1998-12-22,EP 97204081 A;;EP 9808538 W;;US 21851998 A,1997-12-23,HERSTELLUNG VON WASSERFREIEM SODA,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed.,UNIV DELFT TECH,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;VAN ROSMALEN GERDA MARIA,,https://lens.org/044-340-937-386-326,Granted Patent,no,0,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,0,0,,,,DISCONTINUED
114,EP,B1,EP 1042226 B1,146-006-708-055-210,2002-04-10,2002,EP 98966423 A,1998-12-22,EP 98966423 A;;EP 9808538 W;;EP 97204081 A;;US 21851998 A,1997-12-23,PRODUCTION OF WATER-FREE SODA,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed.,UNIV DELFT TECH,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;VAN ROSMALEN GERDA MARIA,,https://lens.org/146-006-708-055-210,Granted Patent,yes,6,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,1,0,,,"CHEMICAL ABSTRACTS, vol. 99, no. 16, 17 October 1983 Columbus, Ohio, US; abstract no. 124927, YANG, WENBIN ET AL: ""A new technology for the manufacture of soda ash by extraction"" XP002064450 & SHANXI DAXUE XUEBAO, ZIRAN KEXUEBAN (1982), 17, 46-9 CODEN: SDXKDT;ISSN: 0253-2395,1982,",EXPIRED
115,ES,T3,ES 2175854 T3,017-423-964-398-140,2002-11-16,2002,ES 98966423 T,1998-12-22,EP 97204081 A;;US 21851998 A,1997-12-23,PRODUCCION DE SOSA EXENTA DE AGUA.,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed.,UNIV DELFT TECH,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;VAN ROSMALEN GERDA MARIA,,https://lens.org/017-423-964-398-140,Granted Patent,no,0,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,0,0,,,,EXPIRED
116,PT,E,PT 1042226 E,077-617-370-798-624,2002-09-30,2002,PT 98966423 T,1998-12-22,EP 97204081 A;;US 21851998 A,1997-12-23,PRODUCAO DE SODA ISENTA DE AGUA,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed.,UNIV DELFT TECH,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;ROSMALEN GERDA MARIA VAN,,https://lens.org/077-617-370-798-624,Granted Patent,no,0,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,0,0,,,,EXPIRED
117,US,B1,US 6334989 B1,141-438-555-930-949,2002-01-01,2002,US 21851998 A,1998-12-22,US 21851998 A;;EP 97204081 A,1997-12-23,Production of water-free soda,"
    A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m ^{ 3 } . The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed. 
",UNIV DELFT TECH,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;VAN ROSMALEN GERDA MARIA,TECHNISCHE UNIVERSITEIT DELFT (2000-04-26),https://lens.org/141-438-555-930-949,Granted Patent,yes,17,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,423/426;;X 23302 T;;423/206.1;;423/427,4,1,074-615-803-710-504,10.1021/ie00051a009,"Chemical Abstracts, vol. 99, 124927 (1983).;;D. A. Weingaertner et al., ""Extractive Crystallization of Salts from Concentrated Aqueous Solution"", Ind. Eng. Chem. Res. 1991, 30, 490-501.;;Chemical Abstracts, vol. 92, 183082v (1980).;;Chemical Abstracts, vol. 99, 124927w (1983).",EXPIRED
118,EP,A1,EP 1042226 A1,072-097-288-267-615,2000-10-11,2000,EP 98966423 A,1998-12-22,EP 98966423 A;;EP 9808538 W;;EP 97204081 A;;US 21851998 A,1997-12-23,PRODUCTION OF WATER-FREE SODA,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed.,UNIV DELFT TECH,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;VAN ROSMALEN GERDA MARIA,,https://lens.org/072-097-288-267-615,Patent Application,yes,0,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,0,0,,,,EXPIRED
119,WO,A1,WO 1999/033750 A1,168-848-333-131-991,1999-07-08,1999,EP 9808538 W,1998-12-22,EP 97204081 A;;US 21851998 A,1997-12-23,PRODUCTION OF WATER-FREE SODA,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atomspheric pressure in the presence of water without the monohydrate of soda being formed.,AKZO NOBEL NV,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;VAN ROSMALEN GERDA MARIA,,https://lens.org/168-848-333-131-991,Patent Application,yes,6,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,1,0,,,"CHEMICAL ABSTRACTS, vol. 99, no. 16, 17 October 1983, Columbus, Ohio, US; abstract no. 124927, YANG, WENBIN ET AL: ""A new technology for the manufacture of soda ash by extraction"" XP002064450",PATENTED
120,WO,A1,WO 2022/076714 A1,002-182-487-519-405,2022-04-14,2022,US 2021/0054011 W,2021-10-07,US 202063089906 P,2020-10-09,SOLID FORMS OF A PAN-JAK INHIBITOR,"The present invention provides amorphous and crystalline hydrate forms of 3-((lR,3s,5S)-3-((7-((5-methyl-lH-pyrazol-3-yl)amino)-l,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, and methods of making and using the same. Formula (I)",JANSSEN BIOTECH INC,DE DOBBELAERE CHRISTOPHER;;EDWARDS RICHARD;;GIELEN BJORN;;GEERTMAN ROBERT MICHAEL;;HARRIS JOE;;ASHURST KATE;;WOMBWELL CLAIRE,,https://lens.org/002-182-487-519-405,Patent Application,yes,3,0,1,1,0,A61P1/04;;C07D451/04,C07D451/04;;A61K31/46;;A61P1/04,,16,14,009-214-187-079-899;;104-949-654-022-72X;;102-397-634-434-297;;004-744-490-817-731;;026-624-461-483-762;;125-824-540-323-893;;151-020-874-836-882;;025-440-963-243-176;;054-434-960-795-902;;006-372-074-802-539;;038-054-407-329-987;;134-126-594-540-496;;006-957-843-406-113;;136-829-642-308-215,10.1023/a:1016241927429;;7494814;;10.1007/3-540-69178-2_5;;10.1097/00042737-199903000-00010;;10333199;;10.1007/bf01540912;;8734357;;10.1016/j.molimm.2013.03.007;;23566938;;23579771;;10.1007/s12026-013-8394-y;;21245483;;10.1182/blood-2010-12-290403;;pmc3069668;;10.1007/s00384-003-0554-4;;14605835;;10.1016/j.autrev.2011.12.005;;22197901;;19787822;;pmc2754507;;10.3748/wjg.15.4609;;18243079;;10.1016/j.dld.2007.11.020;;10.1517/14712598.2014.885945;;24502344;;22115827;;10.1136/gutjnl-2011-300904;;25341118;;10.2217/imt.14.66,"STEPHEN BYRN ET AL: ""Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations"", PHARMACEUTICAL RESEARCH, vol. 12, no. 7, 1 July 1995 (1995-07-01), pages 945 - 954, XP055531015, Retrieved from the Internet <URL:https://link.springer.com/article/10.1023/A:1016241927429> DOI: 10.1023/A:1016241927429;;MINO R CAIRA ED - MONTCHAMP JEAN-LUC: ""CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS"", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, [retrieved on 19990226], DOI: 10.1007/3-540-69178-2_5;;""Remington: The Science and Practice of Pharmacy"", 2000, LIPPINCOTT WILLIAMS & WHITE;;WOYWODT ET AL., EUR J GASTROENTEROLOGY HEPATOLOGY, vol. 11, 1999, pages 267 - 276;;REIMUND ET AL., J CLIN IMMUNOLOGY, vol. 16, 1996, pages 144 - 150;;KUMAWAT ET AL., MOL IMMUNOLOGY, vol. 55, 2013, pages 355 - 364;;WEINBRAND-GOICHBERG ET AL., IMMUNOL RES, vol. 56, 2013, pages 249 - 260;;COGHILL ET AL., BLOOD, vol. 117, 2001, pages 3268 - 3276;;STALLMACH ET AL., INT J COLORECTAL DIS, vol. 19, 2004, pages 308 - 315;;ZHOU ET AL., AUTOIMMUN REV, vol. 11, 2012, pages 699 - 704;;NITTO ET AL., WORLD J GASTROENTEROL, vol. 15, 2009, pages 4609 - 4614;;YANO ET AL., J TRANSLATION MED, vol. 12, 2014, pages 191;;YAMAMOTO ET AL., DIG LIVER DIS, vol. 40, 2008, pages 253 - 259;;MOZAFFARI ET AL., EXPERT OPIN. BIOL. THER., vol. 14, 2014, pages 583 - 600;;DANESE, GUT, vol. 61, 2012, pages 918 - 932;;LAM ET AL., IMMUNOTHERAPY, vol. 6, 2014, pages 963 - 971",PENDING
121,AU,A,AU 1999/022772 A,135-853-374-303-592,1999-07-19,1999,AU 1999/022772 A,1998-12-22,EP 97204081 A;;EP 9808538 W;;US 21851998 A,1997-12-23,Production of water-free soda,A process is presented in which anhydrous soda is crystallized and worked up to produce anhydrous soda crystals with a bulk density from 1300 to 1600 kg/m3. The process is characterized in that a solvent is used that allows the crystals to be formed and handled at atmospheric pressure in the presence of water without the monohydrate of soda being formed.,AKZO NOBEL NV,MEIJER JOHANNES ALBERTUS MARIA;;GEERTMAN ROBERT MICHAEL;;OOSTERHOF HARALD;;WITKAMP GEERT-JAN;;ROSMALEN GERDA MARIA VAN,,https://lens.org/135-853-374-303-592,Patent Application,no,0,0,10,10,0,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/35;;C01D7/37;;C01D7/40;;C01D7/24,C01D7/24;;C01D7/35;;C01D7/37;;C01D7/40,,0,0,,,,DISCONTINUED
122,WO,A1,WO 2022/076717 A1,106-580-069-711-749,2022-04-14,2022,US 2021/0054016 W,2021-10-07,US 202063089913 P,2020-10-09,SOLVATE FORMS OF A PAN-JAK INHIBITOR,"The present invention provides crystalline solvate and solvate/hydrate forms of 3-((1 R ,3 s ,5 S )-3-((7-((5-methyl-1 H -pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, and methods of making and using the same.",JANSSEN BIOTECH INC,DE DOBBELAERE CHRISTOPHER;;COLLAS ALAIN;;EDWARDS RICHARD;;GIELEN BJORN;;GEERTMAN ROBERT MICHAEL;;ASHURST KATE;;WOMBWELL CLAIRE,,https://lens.org/106-580-069-711-749,Patent Application,yes,3,0,1,1,0,A61P1/04;;C07D451/04,A61K31/46;;C07D451/04;;A61P1/04,,19,14,009-214-187-079-899;;104-949-654-022-72X;;102-397-634-434-297;;004-744-490-817-731;;026-624-461-483-762;;125-824-540-323-893;;151-020-874-836-882;;025-440-963-243-176;;054-434-960-795-902;;006-372-074-802-539;;038-054-407-329-987;;134-126-594-540-496;;006-957-843-406-113;;136-829-642-308-215,10.1023/a:1016241927429;;7494814;;10.1007/3-540-69178-2_5;;10.1097/00042737-199903000-00010;;10333199;;10.1007/bf01540912;;8734357;;10.1016/j.molimm.2013.03.007;;23566938;;23579771;;10.1007/s12026-013-8394-y;;21245483;;10.1182/blood-2010-12-290403;;pmc3069668;;10.1007/s00384-003-0554-4;;14605835;;10.1016/j.autrev.2011.12.005;;22197901;;19787822;;pmc2754507;;10.3748/wjg.15.4609;;18243079;;10.1016/j.dld.2007.11.020;;10.1517/14712598.2014.885945;;24502344;;22115827;;10.1136/gutjnl-2011-300904;;25341118;;10.2217/imt.14.66,"STEPHEN BYRN ET AL: ""Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations"", vol. 12, no. 7, 1 July 1995 (1995-07-01), pages 945 - 954, XP055531015, Retrieved from the Internet <URL:https://link.springer.com/article/10.1023/A:1016241927429> DOI: 10.1023/A:1016241927429;;MINO R CAIRA ED - MONTCHAMP JEAN-LUC: ""CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS"", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, [retrieved on 19990226], DOI: 10.1007/3-540-69178-2_5;;CHEMICAL ABSTRACTS , no. 123-51-3;;CHEMICAL ABSTRACTS, no. 127-19-5;;CHEMICAL , no. 80-73-9;;""Remington: The Science and Practice of Pharmacy"", 2000, LIPPINCOTT WILLIAMS & WHITE;;WOYWODT ET AL., EUR J GASTROENTEROLOGY HEPATOLOGY, vol. 11, 1999, pages 267 - 276;;REIMUND ET AL., J CLIN IMMUNOLOGY, vol. 16, 1996, pages 144 - 150;;KUMAWAT ET AL., MOL IMMUNOLOGY, vol. 55, 2013, pages 355 - 364;;WEINBRAND-GOICHBERG ET AL., IMMUNOL RES, vol. 56, 2013, pages 249 - 260;;COGHILL ET AL., BLOOD, vol. 117, 2001, pages 3268 - 3276;;STALLMACH ET AL., INT J COLORECTAL DIS, vol. 19, 2004, pages 308 - 315;;ZHOU ET AL., AUTOIMMUN REV, vol. 11, 2012, pages 699 - 704;;DE NITTO ET AL., WORLD J GASTROENTEROL, vol. 15, 2009, pages 4609 - 4614;;YANO ET AL., J TRANSLATION MED, vol. 12, 2014, pages 191;;YAMAMOTO ET AL., DIG LIVER DIS, vol. 40, 2008, pages 253 - 259;;MOZAFFARI ET AL., EXPERT OPIN. BIOL. THER., vol. 14, 2014, pages 583 - 600;;DANESE, GUT, vol. 61, 2012, pages 918 - 932;;LAM ET AL., IMMUNOTHERAPY, vol. 6, 2014, pages 963 - 971",PENDING
123,WO,A2,WO 2005/121411 A2,125-599-914-340-033,2005-12-22,2005,EP 2005052541 W,2005-06-02,US 57757304 P;;EP 04077826 A,2004-06-08,PROCESS FOR PREVENTING MEMBRANE DEGENERATION USING COMPLEXING AGENTS,"Membrane cell electrolysis process to prepare chlorine from an aqueous salt solution comprising the steps of dissolving a sodium chloride source in water to form an aqueous salt solution comprising sodium chloride, and dosing one or more degeneration reducing agents selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, polycarboxylic acids, polyacrylates, polymaleic acids, and derivatives thereof to said aqueous salt solution in a total amount of, on average, between 0.1 mg and 1,000 mg per litre of aqueous salt solution at a stage of the electrolysis process where the amount of active chlorine dissolved in said aqueous salt solution is less than 1.5 g per litre of aqueous salt solution and/or to the membrane cells, in order to reduce fouling and/or clogging of the membrane in said membrane cell.",AKZO NOBEL NV;;BARGEMAN GERRALD;;DEMMER RENE LODEWIJK MARIA;;GEERTMAN ROBERT MICHAEL;;GIATTI ANNA;;MAYER MATEO JOZEF JACQUES;;BERGEVOET ROBERTO ALOYSIUS GER,BARGEMAN GERRALD;;DEMMER RENE LODEWIJK MARIA;;GEERTMAN ROBERT MICHAEL;;GIATTI ANNA;;MAYER MATEO JOZEF JACQUES;;BERGEVOET ROBERTO ALOYSIUS GER,,https://lens.org/125-599-914-340-033,Patent Application,yes,0,1,3,3,0,C25B1/46;;C01D3/145;;C02F1/46104;;C02F1/683;;C02F5/10;;C02F2201/46115;;C02F2201/46185;;C25B1/34;;C25B13/00;;C25B15/08,B01D61/52;;C01D3/14;;C02F1/461;;C02F1/68;;C02F5/10;;C25B1/34;;C25B13/00;;C25B15/00;;C25B15/08,,0,0,,,,PENDING
124,WO,A3,WO 2005/121411 A3,127-723-263-347-669,2006-06-08,2006,EP 2005052541 W,2005-06-02,US 57757304 P;;EP 04077826 A,2004-06-08,PROCESS FOR PREVENTING MEMBRANE DEGENERATION USING COMPLEXING AGENTS,"Membrane cell electrolysis process to prepare chlorine from an aqueous salt solution comprising the steps of dissolving a sodium chloride source in water to form an aqueous salt solution comprising sodium chloride, and dosing one or more degeneration reducing agents selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, polycarboxylic acids, polyacrylates, polymaleic acids, and derivatives thereof to said aqueous salt solution in a total amount of, on average, between 0.1 mg and 1,000 mg per litre of aqueous salt solution at a stage of the electrolysis process where the amount of active chlorine dissolved in said aqueous salt solution is less than 1.5 g per litre of aqueous salt solution and/or to the membrane cells, in order to reduce fouling and/or clogging of the membrane in said membrane cell.",AKZO NOBEL NV;;BARGEMAN GERRALD;;DEMMER RENE LODEWIJK MARIA;;GEERTMAN ROBERT MICHAEL;;GIATTI ANNA;;MAYER MATEO JOZEF JACQUES;;BERGEVOET ROBERTO ALOYSIUS GER,BARGEMAN GERRALD;;DEMMER RENE LODEWIJK MARIA;;GEERTMAN ROBERT MICHAEL;;GIATTI ANNA;;MAYER MATEO JOZEF JACQUES;;BERGEVOET ROBERTO ALOYSIUS GER,,https://lens.org/127-723-263-347-669,Search Report,yes,3,0,3,3,0,C25B1/46;;C01D3/145;;C02F1/46104;;C02F1/683;;C02F5/10;;C02F2201/46115;;C02F2201/46185;;C25B1/34;;C25B13/00;;C25B15/08,C25B13/00;;B01D61/52;;C01D3/14;;C02F1/461;;C02F1/68;;C02F5/10;;C25B1/34;;C25B15/00;;C25B15/08,,0,0,,,,PENDING
125,DE,D1,DE 602004016311 D1,170-292-053-656-241,2008-10-16,2008,DE 602004016311 T,2004-04-28,US 46676103 P;;EP 2004004506 W,2003-04-29,"VERFAHREN ZUR VERFESTIGUNG, BEI WELCHEM EIN ANTI-LÖSUNGSMITTEL BENUTZT WIRD",,ORGANON NV,BAKKER WRIDZER JAN;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH,,https://lens.org/170-292-053-656-241,Granted Patent,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,ACTIVE
126,EP,A2,EP 1753895 A2,179-063-896-183-866,2007-02-21,2007,EP 05747616 A,2005-06-02,EP 2005052541 W;;US 57757304 P;;EP 04077826 A;;EP 05747616 A,2004-06-08,PROCESS FOR PREVENTING MEMBRANE DEGENERATION USING COMPLEXING AGENTS,,AKZO NOBEL NV,BARGEMAN GERRALD;;DEMMER RENE LODEWIJK MARIA;;GEERTMAN ROBERT MICHAEL;;GIATTI ANNA;;MAYER MATEO JOZEF JACQUES;;BERGEVOET ROBERTO ALOYSIUS GER,,https://lens.org/179-063-896-183-866,Patent Application,yes,0,0,3,3,0,C25B1/46;;C01D3/145;;C02F1/46104;;C02F1/683;;C02F5/10;;C02F2201/46115;;C02F2201/46185;;C25B1/34;;C25B13/00;;C25B15/08,C25B13/00;;B01D61/52;;C01D3/14;;C02F1/461;;C02F1/68;;C02F5/10;;C25B1/34;;C25B15/00;;C25B15/08,,1,0,,,See references of WO 2005121411A3,DISCONTINUED
127,EP,B1,EP 3262902 B1,041-501-585-599-648,2020-06-24,2020,EP 16704224 A,2016-02-12,EP 15156785 A;;EP 2016053055 W,2015-02-26,DRIVER MODULE FOR POWERING A LIGHT SOURCE AND A FURTHER MODULE.,,SIGNIFY HOLDING BV,DEN BOER REINIER IMRE ANTON;;GOIJAERTS ADRIANUS MARIA;;BOULIN YVES SEBASTIEN;;NAIR BIJU KUMAR SREEDHARAN;;GEERTMAN ROBERT EUGENIO MARIE,PHILIPS LIGHTING HOLDING B.V. (2018-12-12);;SIGNIFY HOLDING B.V. (2019-03-13),https://lens.org/041-501-585-599-648,Granted Patent,yes,9,0,5,5,0,H05B47/22;;H05B47/19;;Y02B20/40;;H05B47/19;;H05B47/11;;H05B47/22;;H02J50/12;;F21Y2115/10;;F21S8/086;;F21W2131/103,H05B47/21;;H05B47/19,,0,0,,,,ACTIVE
128,US,A1,US 2018/0035517 A1,145-436-810-383-986,2018-02-01,2018,US 201615551850 A,2016-02-12,EP 15156785 A;;EP 2016053055 W,2015-02-26,DRIVER MODULE FOR POWERING A LIGHT SOURCE AND A FURTHER MODULE,"The present invention relates to a driver module for use in a light fixture, especially an outdoor light fixture. The driver module is arranged for wirelessly powering a further module and for transmitting data from and/or to this further module. The further module can be a sensor module or a communications module. This allows for easy replacement of modules in light fixtures, late stage configuration of light fixtures and for upgradeability of light fixtures.",PHILIPS LIGHTING HOLDING BV,DEN BOER REINIER IMRE ANTON;;GOIJAERTS ADRIANUS MARIA;;BOULIN YVES SEBASTIEN;;NAIR BIJU KUMAR SREEDHARAN;;GEERTMAN ROBERT EUGENIO MARIE,SIGNIFY HOLDING B.V (2016-02-16),https://lens.org/145-436-810-383-986,Patent Application,yes,12,13,5,5,0,H05B47/22;;H05B47/19;;Y02B20/40;;H05B47/19;;H05B47/11;;H05B47/22;;H02J50/12;;F21Y2115/10;;F21S8/086;;F21W2131/103,H05B37/02,,0,0,,,,ACTIVE
129,WO,A1,WO 2016/134992 A1,160-379-377-462-995,2016-09-01,2016,EP 2016053055 W,2016-02-12,EP 15156785 A,2015-02-26,DRIVER MODULE FOR POWERING A LIGHT SOURCE AND A FURTHER MODULE.,"The present invention relates to a driver module for use in a light fixture, especially an outdoor light fixture. The driver module is arranged for wirelessly powering a further module and for transmitting data from and/or to this further module. The further module can be a sensor module or a communications module. This allows for easy replacement of modules in light fixtures, late stage configuration of light fixtures and for upgradeability of light fixtures.",PHILIPS LIGHTING HOLDING BV,DEN BOER REINIER IMRE ANTON;;GOIJAERTS ADRIANUS MARIA;;BOULIN YVES SEBASTIEN;;NAIR BIJU KUMAR SREEDHARAN;;GEERTMAN ROBERT EUGENIO MARIE,,https://lens.org/160-379-377-462-995,Patent Application,yes,9,5,5,5,0,H05B47/22;;H05B47/19;;Y02B20/40;;H05B47/19;;H05B47/11;;H05B47/22;;H02J50/12;;F21Y2115/10;;F21S8/086;;F21W2131/103,H05B37/02;;H05B37/03,,0,0,,,,PENDING
130,US,B2,US 10448487 B2,173-898-072-082-488,2019-10-15,2019,US 201615551850 A,2016-02-12,EP 15156785 A;;EP 2016053055 W,2015-02-26,Driver module for powering a light source and a further module,"The present invention relates to a driver module for use in a light fixture, especially an outdoor light fixture. The driver module is arranged for wirelessly powering a further module and for transmitting data from and/or to this further module. The further module can be a sensor module or a communications module. This allows for easy replacement of modules in light fixtures, late stage configuration of light fixtures and for upgradeability of light fixtures.",SIGNIFY HOLDING BV,DEN BOER REINIER IMRE ANTON;;GOIJAERTS ADRIANUS MARIA;;BOULIN YVES SEBASTIEN;;NAIR BIJU KUMAR SREEDHARAN;;GEERTMAN ROBERT EUGENIO MARIE,SIGNIFY HOLDING B.V (2016-02-16),https://lens.org/173-898-072-082-488,Granted Patent,yes,14,2,5,5,0,H05B47/22;;H05B47/19;;Y02B20/40;;H05B47/19;;H05B47/11;;H05B47/22;;H02J50/12;;F21Y2115/10;;F21S8/086;;F21W2131/103,H05B37/02;;F21S8/08;;F21W131/103;;F21Y115/10;;H02J50/12;;H05B37/03,,0,0,,,,ACTIVE
131,NO,D0,NO 20055607 D0,195-261-367-217-669,2005-11-28,2005,NO 20055607 A,2005-11-28,US 46676103 P;;EP 2004004506 W,2003-04-29,Antilosemiddel solidifiseringsprosess,,AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL;;LARE CORNELIS ELISABETH JOHANN;;BAKKER WRIDZER JAN WILLEM;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD,,https://lens.org/195-261-367-217-669,Patent Application,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,DISCONTINUED
132,EP,A1,EP 3262902 A1,111-402-784-725-807,2018-01-03,2018,EP 16704224 A,2016-02-12,EP 15156785 A;;EP 2016053055 W,2015-02-26,DRIVER MODULE FOR POWERING A LIGHT SOURCE AND A FURTHER MODULE.,,PHILIPS LIGHTING HOLDING BV,DEN BOER REINIER IMRE ANTON;;GOIJAERTS ADRIANUS MARIA;;BOULIN YVES SEBASTIEN;;NAIR BIJU KUMAR SREEDHARAN;;GEERTMAN ROBERT EUGENIO MARIE,PHILIPS LIGHTING HOLDING B.V. (2018-12-12);;SIGNIFY HOLDING B.V. (2019-03-13),https://lens.org/111-402-784-725-807,Patent Application,yes,0,0,5,5,0,H05B47/22;;H05B47/19;;Y02B20/40;;H05B47/19;;H05B47/11;;H05B47/22;;H02J50/12;;F21Y2115/10;;F21S8/086;;F21W2131/103,H05B37/02;;H05B37/03,,0,0,,,,ACTIVE
133,AU,A1,AU 2004/234057 A1,182-046-864-045-382,2004-11-11,2004,AU 2004/234057 A,2004-04-28,US 46676103 P;;EP 2004004506 W,2003-04-29,Antisolvent solidification process,,AKZO NOBEL NV,BALTUSSEN JOZEF JOHANNES MARIA;;LARE CORNELIS ELIZABETH JOHANN;;BAKKER WRIDZER JAN WILLEM;;BARGEMAN GERRALD;;REEDIJK MARIANNE FREDERIKA;;GEERTMAN ROBERT MICHAEL,,https://lens.org/182-046-864-045-382,Patent Application,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,DISCONTINUED
134,CN,A,CN 1780670 A,124-643-520-533-974,2006-05-31,2006,CN 200480011333 A,2004-04-28,US 46676103 P,2003-04-29,Antisolvent solidification process,,AKZO NOBEL NV,WILLEM BAKKER WRIDZER JAN;;MICHAEL GEERTMAN ROBERT;;FREDERIKA REEDIJK MARIANNE;;MARIA BALTUSSEN JOZEF JOHANNES;;GERRALD BARGEMAN;;JOHANN LARE CORNELIS ELISABETH,ORGANON NV (2008-01-11),https://lens.org/124-643-520-533-974,Patent Application,no,0,6,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,INACTIVE
135,BR,A,BR PI0409860 A,047-684-201-807-368,2006-05-16,2006,BR PI0409860 A,2004-04-28,US 46676103 P;;EP 2004004506 W,2003-04-29,processo de solidificação anti-solvente,"""PROCESSO DE SOLIDIFICAçãO ANTI-SOLVENTE"". A presente invenção refere-se a um processo de solidificação anti-solvente, em que um meio líquido, compreendendo pelo menos um composto orgânico ou inorgânico a ser solidificado, é forçado através de uma membrana a se juntarem a um ou mais anti-solventes ou em que um ou mais anti-solventes são forçados através de uma membrana a se juntar a um meio líquido compreendendo pelo menos um composto orgânico ou inorgânico a ser solidificado, produzindo uma composição que compreende partículas sólidas compreendendo o(s) dito(s) composto(s) orgânico(s) e/ou inorgânico(s).",AKZO NOBEL NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;LARE CONELIS ELIZABETH JOHANNU,N.V. ORGANON (NL) (2009-02-17),https://lens.org/047-684-201-807-368,Patent Application,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,DISCONTINUED
136,CN,C,CN 100434133 C,012-550-158-127-557,2008-11-19,2008,CN 200480011333 A,2004-04-28,US 46676103 P,2003-04-29,Antisolvent solidification process,,AKZO NOBEL NV,WILLEM BAKKER WRIDZER JAN;;MICHAEL GEERTMAN ROBERT;;FREDERIKA REEDIJK MARIANNE;;MARIA BALTUSSEN JOZEF JOHANNES;;GERRALD BARGEMAN;;JOHANN LARE CORNELIS ELISABETH,ORGANON NV (2008-01-11),https://lens.org/012-550-158-127-557,Granted Patent,no,8,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,INACTIVE
137,EP,B1,EP 1620193 B1,036-251-913-282-309,2008-09-03,2008,EP 04729890 A,2004-04-28,EP 2004004506 W;;US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,,ORGANON NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JO,"MSD OSS B.V., NL (2012-02-07);;MERCK SHARP & DOHME B.V., NL (2013-07-05);;N.V. ORGANON (2008-01-23);;MERCK SHARP & DOHME B.V. (2013-09-03);;MERCK SHARP AND DOHME B.V., NL (2013-05-31);;ORGANON BIO SCIENCES NEDERLAND B.V., NL (2013-05-31);;MSD OSS B.V. (2012-04-23)",https://lens.org/036-251-913-282-309,Granted Patent,yes,2,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,ACTIVE
138,US,A1,US 2013/0131029 A1,198-661-118-096-255,2013-05-23,2013,US 201313737061 A,2013-01-09,US 201313737061 A;;US 201113099926 A;;US 55321105 A;;EP 2004004506 W;;US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",MSD OSS BV;;MSD OSS BV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS,ORGANON BIOSCIENCES NEDERLAND B.V (2013-01-01);;MERCK SHARP & DOHME B.V (2013-01-02),https://lens.org/198-661-118-096-255,Patent Application,yes,1,39,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/14;;A61K9/16;;C01D3/24;;C07J1/00;;C07J7/00,514/171;;423/499.5;;552/526;;552/607;;552/605;;423/499.4;;427/212;;427/2.14;;427/220;;427/215,0,0,,,,DISCONTINUED
139,WO,A1,WO 2004/096405 A1,074-019-176-625-94X,2004-11-11,2004,EP 2004004506 W,2004-04-28,US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",AKZO NOBEL NV;;BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JO,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JO,,https://lens.org/074-019-176-625-94X,Patent Application,yes,2,2,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,PATENTED
140,EP,A1,EP 1620193 A1,087-459-391-972-603,2006-02-01,2006,EP 04729890 A,2004-04-28,EP 2004004506 W;;US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,,AKZO NOBEL NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JO,"MSD OSS B.V., NL (2012-02-07);;MERCK SHARP & DOHME B.V., NL (2013-07-05);;N.V. ORGANON (2008-01-23);;MERCK SHARP & DOHME B.V. (2013-09-03);;MERCK SHARP AND DOHME B.V., NL (2013-05-31);;ORGANON BIO SCIENCES NEDERLAND B.V., NL (2013-05-31);;MSD OSS B.V. (2012-04-23)",https://lens.org/087-459-391-972-603,Patent Application,yes,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,ACTIVE
141,NO,L,NO 20055607 L,004-142-605-846-025,2005-11-28,2005,NO 20055607 A,2005-11-28,US 46676103 P;;EP 2004004506 W,2003-04-29,Antilosemiddel solidifiseringsprosess,"Forehggende oppfirmelse omhandler en antiløsemiddel sohdifiseringsprosess hvori et flytende medium som omfatter minst én organisk eller uorganisk forbindelse som skal solidifiseres blfr tvunget gjermom en membran irm i ett eller flere antiløsemidler, eller hvori ett eller flere antiløsemidler blir tvunget gjermom en membran irm i et flytende medium som omfatter minst én organisk eller uorganisk forbindelse som skal solidifiseres, hvilket gir en sammensetning som omfatter faste partikler som omfatter nevnte organiske og/eller uorganiske forbindelse(r).",AKZO NOBEL NV,GEERTMAN ROBERT MICHAEL;;LARE CORNELIS ELISABETH JOHANN;;BAKKER WRIDZER JAN WILLEM;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD,,https://lens.org/004-142-605-846-025,Abstract,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/02;;A61K9/16;;B01D9/00,,0,0,,,,DISCONTINUED
142,US,A1,US 2006/0182808 A1,078-750-837-127-699,2006-08-17,2006,US 55321105 A,2005-12-08,US 55321105 A;;US 46676103 P;;EP 2004004506 W,2003-04-29,Antisolvent solidification process,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",AKZO NOBEL NV,BAKKER WRIDZER J W;;GEERTMAN ROBERT M;;REEDIJK MARIANNE F;;BALTUSSEN JOZEF J M;;BARGEMAN GERRALD;;VAN LARE CORNELIS E J,N.V. ORGANON (2007-10-29);;AKZO NOBEL N.V (2005-11-04),https://lens.org/078-750-837-127-699,Patent Application,yes,26,19,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K31/57;;A61K9/14;;A61K9/16;;B01D9/00,424/489;;514/177,0,0,,,,DISCONTINUED
143,KR,A,KR 20060006949 A,009-043-790-300-486,2006-01-20,2006,KR 20057020462 A,2005-10-28,US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",AKZO NOBEL NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JO,,https://lens.org/009-043-790-300-486,Patent Application,no,0,1,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,DISCONTINUED
144,CA,C,CA 2523883 C,137-166-340-298-690,2012-01-03,2012,CA 2523883 A,2004-04-28,US 46676103 P;;EP 2004004506 W,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",AKZO NOBEL NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS,,https://lens.org/137-166-340-298-690,Granted Patent,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,INACTIVE
145,US,A1,US 2011/0268806 A1,047-661-615-971-377,2011-11-03,2011,US 201113099926 A,2011-05-03,US 201113099926 A;;US 55321105 A;;US 46676103 P;;EP 2004004506 W,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",ORGANON USA INC,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS,MSD OSS B.V (2011-10-31),https://lens.org/047-661-615-971-377,Patent Application,yes,6,1,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/14;;A61K9/16;;A61K31/56;;A61K33/14;;A61P5/24;;B01D9/00,424/490;;424/680;;514/178;;514/177,2,2,001-005-004-178-324;;068-562-334-107-708,11745720;;10.1002/jps.1112;;10.1254/jjp.29.509;;537269,"Nocent (J. Pharm. Sci, 90, 1620-1627) Definition of a solvent for spherical....;;Nakagawa (Japan J. Pharmacol. 29, 509-514, 1979) Antiinflammatory action of progesterone...",DISCONTINUED
146,HK,A1,HK 1088268 A1,070-857-778-370-910,2006-11-03,2006,HK 06108874 A,2006-08-10,EP 2004004506 W;;US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,,ORGANON NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;LARE CORNELIS ELIZABETH JOHANNUS VAN,,https://lens.org/070-857-778-370-910,Patent Application,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D/;;B01D9/00,,0,0,,,,DISCONTINUED
147,US,A1,US 2012/0232296 A1,065-270-630-246-944,2012-09-13,2012,US 201213481088 A,2012-05-25,US 201213481088 A;;US 201113099926 A;;US 55321105 A;;EP 2004004506 W;;US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARJANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS;;ORGANON USA INC,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARJANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS,,https://lens.org/065-270-630-246-944,Patent Application,yes,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,C07J1/00;;A61K9/16;;B01D9/00;;C07J7/00,552/526;;552/645;;552/607,0,0,,,,DISCONTINUED
148,TW,A,TW 200500095 A,164-128-483-322-418,2005-01-01,2005,TW 93112056 A,2004-04-29,US 46676103 P,2003-04-29,Antisolvent solidification process,"The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",AKZO NOBEL NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELISABETH JOHANNUS,,https://lens.org/164-128-483-322-418,Patent of Addition,no,0,1,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,PENDING
149,CA,A1,CA 2523883 A1,041-389-399-921-827,2004-11-11,2004,CA 2523883 A,2004-04-28,US 46676103 P;;EP 2004004506 W,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"The present invention relates to a antisolvent solidification process wherei n a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprisi ng said organic and/or inorganic compound(s).",AKZO NOBEL COATINGS INT BV,GEERTMAN ROBERT MICHAEL;;BAKKER WRIDZER JAN WILLEM;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;VAN LARE CORNELIS ELIZABETH JO;;BARGEMAN GERRALD,,https://lens.org/041-389-399-921-827,Patent Application,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,INACTIVE
150,ZA,B,ZA 200509597 B,168-898-291-704-397,2006-12-27,2006,ZA 200509597 A,2005-11-28,US 46676103 P,2003-04-29,Antisolvent solidification process,,AKZO NOBEL NV,WILLEM BAKKER WRIDZER JAN;;FREDERIKA REEDIJK MARIANNE;;GERRALD BARGEMAN;;MICHAEL GEERTMAN ROBERT;;MARIA BALTUSSEN JOZEF JOHANNES;;VAN LARA CORNELIS ELIZABETH JOHANNUS,,https://lens.org/168-898-291-704-397,Granted Patent,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D/;;B01D9/00,,0,0,,,,ACTIVE
151,ES,T3,ES 2312996 T3,197-128-782-803-470,2009-03-01,2009,ES 04729890 T,2004-04-28,US 46676103 P,2003-04-29,PROCESO DE SOLIDIFICACION CON ANTIDISOLVENTE.,"Proceso de solidificación con antidisolvente para preparar una composición sólida que comprende al menos un compuesto orgánico o inorgánico, en el que un medio líquido que comprende al menos un compuesto orgánico o inorgánico disuelto se fuerza a través de una membrana que está situada en un módulo de membrana hacia uno o más antidisolventes o en el que uno o más antidisolventes se fuerzan a través de una membrana que está situada en un módulo de membrana hacia un medio líquido que comprende al menos un compuesto orgánico o inorgánico, con lo que el proceso se realiza como un proceso continuo y con lo que la membrana tiene poros de hasta 3 mum y la forma de la membrana se selecciona entre tubos, fibras o bobinados espirales, produciendo una composición que comprende partículas sólidas que comprenden dicho compuesto o compuestos orgánicos y/o inorgánicos.",ORGANON NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS,,https://lens.org/197-128-782-803-470,Granted Patent,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,ACTIVE
152,NZ,A,NZ 543772 A,021-969-040-935-347,2009-05-31,2009,NZ 54377204 A,2004-04-28,US 46676103 P;;EP 2004004506 W,2003-04-29,Antisolvent crystallisation process using membranes for the purification of inorganic or organic compositions,"Antisolvent solidification process for preparing a solid composition comprising at least one organic or inorganic compound is disclosed, wherein, a liquid medium comprising at least one dissolved organic or inorganic compound is forced through a membrane which is positioned in a membrane module into one or more antisolvents or wherein one or more antisolvents are forced through a membrane which is positioned in a membrane module into a liquid medium comprising at least one organic or inorganic compound, and whereby the process is carried out as a continuous process. and wherein the membrane has up to 3 11m pores and the shape of the membrane is selected from tubes, fibres or spiral wounds, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).",ORGANON NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;REEDIJK MARIANNE FREDERIKA;;BALTUSSEN JOZEF JOHANNES MARIA;;BARGEMAN GERRALD;;VAN LARE CORNELIS ELIZABETH JOHANNUS,"N.V. ORGANON, NL (2008-02-29)",https://lens.org/021-969-040-935-347,Patent Application,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,A61K9/16;;B01D9/00,,0,0,,,,PENDING
153,MY,A,MY 141189 A,188-722-867-296-08X,2010-03-31,2010,MY PI20041619 A,2004-04-29,US 46676103 P,2003-04-29,ANTISOLVENT SOLIDIFICATION PROCESS,"THE PRESENT INVENTION RELATES TO A ANTISOLVENT SOLIDIFICATION PROCESS WHEREIN A LIQUID MEDIUM COMPRISING AT LEAST ONE ORGANIC OR INORGANIC COMPOUND WHICH IS TO BE SOLIDIFIED IS FORCED THROUGH A MEMBRANE INTO ONE OR MORE ANTISOLVENTS, OR WHEREIN ONE OR MORE ANTISOLVENTS ARE FORCED THROUGH A MEMBRANE INTO A LIQUID MEDIUM COMPRISING AT LEAST ONE ORGANIC OR INORGANIC COMPOUND WHICH IS TO BE SOLIDIFIED, YIELDING A COMPOSITION COMPRISING SOLID PARTICLES COMPRISING SAID ORGANIC AND/OR INORGANIC COMPOUND(S).",ORGANON NV,BAKKER WRIDZER JAN WILLEM;;GEERTMAN ROBERT MICHAEL;;BALTUSSEN JOZEF JOHANNES MARIA;;REEDIJK MARIANNE FREDERIKA;;BARGEMAN GERRALD;;LARE CORNELIS ELISABETH JOHANNES VAN,,https://lens.org/188-722-867-296-08X,Granted Patent,no,0,0,32,32,0,A61K9/1688;;A61K31/57;;A61P5/24;;A61P5/38;;B01D9/0054;;B01D9/00;;A61K31/57;;B01D9/005;;A61K9/1688;;A61K9/14;;B01D9/0063;;C01D3/24;;C07J1/00;;C07J7/0005;;C07J7/0045,B01D9/00;;A61K9/16,,0,0,,,,ACTIVE
154,UY,A,UY 39823 A,189-308-390-244-874,2023-01-31,2023,UY 39823 A,2022-06-17,CN 2021100466 W;;CN 2022091677 W,2021-06-17,"SAL DE TIPO BESILATO DE (R)-N-ETIL-5-FLUORO-N-ISOPROPIL-2-((5-(2-(6-((2-METOXIETIL)(METIL)AMINO)-2-METILHEXAN-3-IL)-2,6- DIAZAESPIRO[3.4]OCTAN-6-IL)-1,2,4-TRIAZIN-6-IL)OXI)BENZAMIDA","La presente invención se refiere a la sal de tipo besilato de (R)-N-etil-5-fluoro-N-isopropil-2-((5-(2-(6-((2-metoxietil)(metil)amino)-2-metilhexan-3-il)-2,6-diazaespiro[3.4]octan-6-il)-1,2,4-triazin-6-il)oxi)benzamida y solvatos de esta. Este compuesto puede ser útil para la terapia y/o profilaxis en un mamífero, una composición farmacéutica que comprende tal compuesto y su uso como inhibidor de la interacción proteína/proteína de la menina/MLL, útil para tratar enfermedades tales como el cáncer, que incluye, entre otros, leucemia, síndrome mielodisplásico (MDS) y neoplasias mieloproliferativas (MPN); y diabetes.",JANSSEN PHARMACEUTICA NV,GEERTMAN ROBERT MICHAEL;;CAI WEI;;QUEROLLE OLIVIER ALEXIS GEORGES;;LIU YINGTAO;;DARVILLE NICOLAS FREDDY J;;DAI XUEDONG;;NG ALICIA TEE FUAY;;CLEATOR EDWARD;;PANDE VINEET;;THURING JOHANNES WILHELMUS J;;AHUJA DIPALI;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/189-308-390-244-874,Patent Application,no,0,0,9,9,0,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,A61P35/00;;A61K31/407;;A61K31/53;;A61P35/02;;C07D253/07;;C07D487/10,,0,0,,,,PENDING
155,CA,A1,CA 3220099 A1,021-326-525-519-465,2022-12-22,2022,CA 3220099 A,2022-06-16,CN 2021100466 W;;CN 2022091677 W;;CN 2022099089 W,2021-06-17,"(R)-N-ETHYL-5-FLUORO-N-ISOPROPYL-2-((5-(2-(6-((2-METHOXYETHYL)(METHYL)AMINO)-2-METHYLHEXAN-3-YL)-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-1,2,4-TRIAZIN-6-YL)OXY)BENZAMIDE BESYLATE SALT FOR THE TREATMENT OF DISEASES SUCH AS CANCE","The present invention relates to (R) -N-ethyl-5-fluoro-N-isopropyl-2- ( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhexan-3-yl) -2, 6-diazaspiro [3.4] octan-6-yl) -1, 2, 4-triazin-6-yl) oxy) benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.",JANSSEN PHARMACEUTICA NV,CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YINGTAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/021-326-525-519-465,Patent Application,no,0,0,9,9,1,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,C07D487/04;;C07D487/10,,0,0,,,,PENDING
156,IL,A,IL 309359 A,051-264-913-257-441,2024-02-01,2024,IL 30935923 A,2023-12-13,CN 2021100466 W;;CN 2022091677 W;;CN 2022099089 W,2021-06-17,"(r)-n-ethyl-5-fluoro-n-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt for the treatment of diseases such as cancer",,JANSSEN PHARMACEUTICA NV;;CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YINGTAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YINGTAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/051-264-913-257-441,Patent Application,no,0,0,9,9,0,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,A61P35/00,,0,0,,,,PENDING
157,WO,A1,WO 2022/262796 A1,002-362-939-377-750,2022-12-22,2022,CN 2022099089 W,2022-06-16,CN 2021100466 W;;CN 2022091677 W,2021-06-17,"(R)-N-ETHYL-5-FLUORO-N-ISOPROPYL-2-((5-(2-(6-((2-METHOXYETHYL)(METHYL)AMINO)-2-M ETHYLHEXAN-3-YL)-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-1,2,4-TRIAZIN-6-YL)OXY)BENZAMIDE BESYLATE SALT FOR THE TREATMENT OF DISEASES SUCH AS CANCER","The present invention relates to (R) -N-ethyl-5-fluoro-N-isopropyl-2- ( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhexan-3-yl) -2, 6-diazaspiro [3.4] octan-6-yl) -1, 2, 4-triazin-6-yl) oxy) benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.",JANSSEN PHARMACEUTICA NV;;JOHNSON & JOHNSON CHINA INVEST LTD,CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YINGTAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/002-362-939-377-750,Patent Application,yes,27,0,9,9,1,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00;;C07C1/00;;C07D487/10,,24,22,057-251-582-404-616;;029-287-106-641-206;;155-781-278-935-667;;072-717-264-286-795;;138-813-912-728-356;;007-418-274-449-167;;007-847-582-830-061;;041-794-992-659-670;;034-921-313-084-736;;108-970-602-425-684;;002-055-818-598-522;;000-138-801-428-114;;035-249-120-920-287;;035-529-394-597-743;;016-017-763-773-717;;052-873-707-433-23X;;053-145-853-274-768;;025-448-409-453-658;;074-260-736-715-515;;003-823-169-332-980;;003-823-169-332-980;;004-324-136-280-950,10.1111/j.1365-2141.2010.08459.x;;21118195;;10.1002/pbc.20944;;16807916;;24813891;;pmc4120120;;10.1016/j.celrep.2014.04.015;;10.1038/leu.2013.135;;23628958;;pmc3826032;;22829075;;pmc3536020;;10.1002/bies.201200007;;10.1158/0008-5472.can-13-3602;;25082813;;10.1016/j.ccr.2008.05.003;;18598942;;pmc2692591;;16415155;;10.1073/pnas.0510347103;;pmc1326489;;10.1016/j.cell.2005.09.025;;16239140;;25817203;;10.1016/j.ccell.2015.02.016;;pmc4415852;;10.4155/fmc.13.214;;24635524;;pmc4138051;;pmc3778547;;23908472;;10.1182/blood-2013-03-486647;;pmc4390530;;25822367;;10.1038/nm.3830;;26744767;;10.1021/acs.jmedchem.5b01305.s001;;pmc5092235;;10.1021/acs.jmedchem.5b01305;;pmc3401603;;10.1038/nchembio.773;;22286128;;27528435;;10.1016/j.bmcl.2016.07.074;;24472025;;pmc3983337;;10.1021/jm401868d;;31821784;;10.3410/f.737064540.793581830;;pmc7227117;;10.1016/j.ccell.2019.11.001;;10.1016/j.vascn.2018.02.004;;29421525;;10.1016/j.stemcr.2018.11.007;;pmc6294263;;30540961;;10.1016/j.stemcr.2018.11.007;;pmc6294263;;30540961;;10.1054/bjoc.2001.1796;;pmc2363645;;11355958,"MARSCHALEK, BR J HAEMATOL, vol. 152, no. 2, 2011, pages 141 - 54;;TOMIZAWA ET AL., PEDIATR BLOOD CANCER, vol. 49, no. 2, 2007, pages 127 - 32;;MISHRA ET AL., CELL REP, vol. 7, no. 4, 2014, pages 1239 - 47;;MEYER ET AL., LEUKEMIA, vol. 27, 2013, pages 2165 - 2176;;THIEL ET AL., BIOESSAYS, vol. 34, 2012, pages 771 - 80;;CERMAKOVA ET AL., CANCER RES, vol. 15, 2014, pages 5139 - 51;;YOKOYAMACLEARY, CANCER CELL, vol. 8, 2008, pages 36 - 46;;CHEN ET AL., PROC NATL ACAD SCI, vol. 103, 2006, pages 1018 - 23;;YOKOYAMA ET AL., CELL, vol. 123, 2005, pages 207 - 18;;BORKIN ET AL., CANCER CELL, vol. 27, 2015, pages 589 - 602;;CIERPICKIGREMBECKA, FUTURE MED CHEM, vol. 6, 2014, pages 447 - 462;;LI ET AL., BLOOD, vol. 122, 2013, pages 2039 - 2046;;MALIK ET AL., NAT MED, vol. 21, 2015, pages 344 - 52;;J MED CHEM, vol. 59, 2016, pages 892 - 913;;NATURE CHEMICAL BIOLOGY, vol. 8, March 2012 (2012-03-01), pages 277 - 284;;REN, J. ET AL., BIOORG MED CHEM LETT, vol. 26, no. 18, 2016, pages 4472 - 4476;;JMED CHEM, vol. 57, 2014, pages 1543 - 1556;;KRIVTSOV ET AL., CANCER CELL, vol. 36, no. 6, 2019, pages 660 - 673;;GENNARO ET AL.: ""Remington's Pharmaceutical Sciences"", 1990, MACK PUBLISHING COMPANY, article ""Pharmaceutical preparations and their Manufacture"";;IVAN KOPLJAR ET AL., JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, vol. 91, 2018, pages 80 - 86;;LU ET AL., TOX SCI, vol. 170, no. 2, 2019, pages 345 - 356;;KOPLJAR ET AL., STEM CELL REPORTS, November 2018 (2018-11-01), pages 1365 - 1377;;KOPLJAR ET AL., STEM CELL REPORTS, vol. 11, 2018, pages 1365 - 1377;;JOHNSON JI ET AL., BR J CANCER, vol. 84, no. 10, 2001, pages 1424 - 1431",PENDING
158,TW,A,TW 202315636 A,112-700-804-296-23X,2023-04-16,2023,TW 111122342 A,2022-06-16,CN 2021100466 W;;CN 2022091677 W,2021-06-17,"(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt","The present invention relates to (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.",JANSSEN PHARMACEUTICA NV,CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY J;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YING-TAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/112-700-804-296-23X,Patent of Addition,no,0,0,9,9,0,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,A61K31/53;;A61K31/397;;A61K31/40;;A61P35/00;;C07C1/00;;C07C231/02;;C07D487/04;;C07D487/10,,0,0,,,,PENDING
159,AU,A1,AU 2022/292697 A1,000-892-320-799-234,2024-02-01,2024,AU 2022/292697 A,2022-06-16,CN 2021100466 W;;CN 2022091677 W;;CN 2022099089 W,2021-06-17,"(R)-N-ETHYL-5-FLUORO-N-ISOPROPYL-2-((5-(2-(6-((2-METHOXYETHYL)(METHYL)AMINO)-2-METHYLHEXAN-3-YL)-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-1,2,4-TRIAZIN-6-YL)OXY)BENZAMIDE BESYLATE SALT FOR THE TREATMENT OF DISEASES SUCH AS CANCER","The present invention relates to (R) -N-ethyl-5-fluoro-N-isopropyl-2- ( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhexan-3-yl) -2, 6-diazaspiro [3.4] octan-6-yl) -1, 2, 4-triazin-6-yl) oxy) benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.",JANSSEN PHARMACEUTICA NV,CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YINGTAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/000-892-320-799-234,Patent Application,no,0,0,9,9,0,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00;;C07C1/00;;C07D487/10,,0,0,,,,PENDING
160,CO,A2,CO 2023018577 A2,023-624-790-045-625,2024-01-15,2024,CO 2023018577 A,2023-12-28,CN 2022099089 W;;CN 2021100466 W;;CN 2022091677 W,2021-06-17,"Sal de besilato de (r)-n-etil-5-fluoro-n-isopropil-2-((5-(2-(6-((2-metoxietil)(metil)amino)-2-metilhexan-3-il)-2,6-diazaspiro[3.4]octan-6-il)-1,2,4-triazin-6-il)oxi)benzamida para el tratamiento de enfermedades tales como el cáncer","La presente invención se relaciona con la sal de besilato de (R)-N-etil-5-fluoro-N-isopropil-2-((5-(2-(6-(2-metoxietil)(metil)amino)-2-metilhexan-3-il)-2,6-diazaespiro[3.4]octan-6-il)-1, 2, 4-triazin-6-il)oxi)benzamida y solvatos de esta. Este compuesto puede ser útil para la terapia y/o profilaxis en un mamífero, composición farmacéutica que comprende tal compuesto, y uso como inhibidor de la interacción entre menina/proteína MLL/proteína, útiles para tratar enfermedades tales como el cáncer, que incluye, sin limitarse a, leucemia, síndrome mielodisplásico (SMD) y neoplasias mieloproliferativas (NMP); y diabetes.",JANSSEN PHARMACEUTICA NV,PANDE VINEET;;CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;LIU YINGTAO;;NG ALICIA TEE FUAY;;THURING JOHANNES WILHELMUS J;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/023-624-790-045-625,Patent Application,no,0,0,9,9,0,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00;;C07C1/00;;C07D487/10,,0,0,,,,PENDING
161,WO,A8,WO 2022/262796 A8,184-491-797-189-72X,2023-03-23,2023,CN 2022099089 W,2022-06-16,CN 2021100466 W;;CN 2022091677 W,2021-06-17,"(R)-N-ETHYL-5-FLUORO-N-ISOPROPYL-2-((5-(2-(6-((2-METHOXYETHYL)(METHYL)AMINO)-2-METHYLHEXAN-3-YL)-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-1,2,4-TRIAZIN-6-YL)OXY)BENZAMIDE BESYLATE SALT FOR THE TREATMENT OF DISEASES SUCH AS CANCER","The present invention relates to (R) -N-ethyl-5-fluoro-N-isopropyl-2- ( (5- (2- (6- ( (2-methoxyethyl) (methyl) amino) -2-methylhexan-3-yl) -2, 6-diazaspiro [3.4] octan-6-yl) -1, 2, 4-triazin-6-yl) oxy) benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.",JANSSEN PHARMACEUTICA NV;;JOHNSON & JOHNSON CHINA INVEST LTD,CAI WEI;;DAI XUEDONG;;QUEROLLE OLIVIER ALEXIS GEORGES;;THURING JOHANNES WILHELMUS J;;NG ALICIA TEE FUAY;;DARVILLE NICOLAS FREDDY JACQUES BRUNO;;GEERTMAN ROBERT MICHAEL;;AHUJA DIPALI;;LIU YINGTAO;;PANDE VINEET;;CLEATOR EDWARD;;BEN HAIM CYRIL;;SMOLDERS SIMON JAN C,,https://lens.org/184-491-797-189-72X,Amended Application,yes,0,0,9,9,0,C07D487/10;;A61P35/00;;C07C231/02;;C07D487/10;;C07C231/02;;C07C235/60;;A61P35/00,C07D487/04;;A61K31/53;;A61P35/00;;C07C1/00;;C07D487/10,,0,0,,,,PENDING
